BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;. [PMID: 27144627 DOI: 10.1053/j.gastro.2016.02.031] [Cited by in Crossref: 1039] [Cited by in F6Publishing: 562] [Article Influence: 207.8] [Reference Citation Analysis]
Number Citing Articles
1 Parfenov AI, Akhmadullina OV, Sabelnikova EA, Belostotsky NI, Kirova MV, Khomeriki SG, Bykova SV. [Disaccharidase deficiency and functional bowel diseases]. Ter Arkh 2017;89:45-52. [PMID: 28514399 DOI: 10.17116/terarkh201789445-52] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nilholm C, Roth B, Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients 2019;11:E1662. [PMID: 31330810 DOI: 10.3390/nu11071662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
3 Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol 2018;3:252-62. [PMID: 29396034 DOI: 10.1016/S2468-1253(18)30003-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 14] [Article Influence: 27.3] [Reference Citation Analysis]
4 Barone M, Gemello E, Viggiani MT, Cristofori F, Renna C, Iannone A, Di Leo A, Francavilla R. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial. Nutrients 2020;12:E705. [PMID: 32155878 DOI: 10.3390/nu12030705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Lee C, Doo E, Choi JM, Jang SH, Ryu HS, Lee JY, Oh JH, Park JH, Kim YS; Brain-Gut Axis Research Group of Korean Society of Neurogastroenterology and Motility. The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil 2017;23:349-62. [PMID: 28672433 DOI: 10.5056/jnm16220] [Cited by in Crossref: 78] [Cited by in F6Publishing: 61] [Article Influence: 19.5] [Reference Citation Analysis]
6 Simrén M, Törnblom H, Palsson OS, van Tilburg MAL, Van Oudenhove L, Tack J, Whitehead WE. Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut 2018;67:255-62. [DOI: 10.1136/gutjnl-2016-312361] [Cited by in Crossref: 98] [Cited by in F6Publishing: 73] [Article Influence: 24.5] [Reference Citation Analysis]
7 Mumolo MG, Rettura F, Melissari S, Costa F, Ricchiuti A, Ceccarelli L, de Bortoli N, Marchi S, Bellini M. Is Gluten the Only Culprit for Non-Celiac Gluten/Wheat Sensitivity? Nutrients 2020;12:E3785. [PMID: 33321805 DOI: 10.3390/nu12123785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Gómez-Escudero O, Remes-Troche JM. Approach to the adult patient with chronic diarrhea: a literature review. Rev Gastroenterol Mex 2021:S0375-0906(21)00038-0. [PMID: 34074557 DOI: 10.1016/j.rgmx.2021.02.002] [Reference Citation Analysis]
9 Shah ED, Almario CV, Spiegel BM, Chey WD. Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study. Am J Gastroenterol 2020;115:294-301. [PMID: 31913193 DOI: 10.14309/ajg.0000000000000502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
10 Zhou Q, Wesselmann U, Walker L, Lee L, Zeltzer L, Verne GN. AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome. J Pain 2018;19:257-63. [PMID: 29079542 DOI: 10.1016/j.jpain.2017.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Huerta PA, Cifuentes M, Levenstein C, Kriebel D. The Association of Occupational Psychosocial Factors with the Prevalence of Irritable Bowel Syndrome in the Chilean Working Population. Ann Work Expo Health 2019;63:426-36. [PMID: 30877302 DOI: 10.1093/annweh/wxz017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Patcharatrakul T, Juntrapirat A, Lakananurak N, Gonlachanvit S. Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production. Nutrients. 2019;11:2856. [PMID: 31766497 DOI: 10.3390/nu11122856] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
13 Bonfrate L, Di Palo DM, Celano G, Albert A, Vitellio P, De Angelis M, Gobbetti M, Portincasa P. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. Eur J Clin Invest 2020;50:e13201. [PMID: 31960952 DOI: 10.1111/eci.13201] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]
14 Costanzini A, Ruzza C, Neto JA, Sturaro C, Malfacini D, Sternini C, De Giorgio R, Calò G. Pharmacological characterization of naloxegol: In vitro and in vivo studies. Eur J Pharmacol 2021;903:174132. [PMID: 33933466 DOI: 10.1016/j.ejphar.2021.174132] [Reference Citation Analysis]
15 Clevers E, Vaes B, Henrard S, Goderis G, Tack J, Törnblom H, Simrén M, Van Oudenhove L. Health problems associated with irritable bowel syndrome: analysis of a primary care registry. Aliment Pharmacol Ther 2018;47:1349-57. [DOI: 10.1111/apt.14612] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Martins CP, Chaves CHA, Castro MGB, Gomes IC, Passos MDCF. Prevalence of small intestine bacterial overgrowth in patients with gastrointestinal symptoms. Arq Gastroenterol. 2017;54:91-95. [PMID: 28273273 DOI: 10.1590/s0004-2803.201700000-06] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Bouchoucha M, Fysekidis M, Rompteaux P, Airinei G, Sabate JM, Benamouzig R. Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects. J Neurogastroenterol Motil 2019;25:258-66. [PMID: 30982242 DOI: 10.5056/jnm18167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
18 Hetterich L, Stengel A. Psychotherapeutic Interventions in Irritable Bowel Syndrome. Front Psychiatry 2020;11:286. [PMID: 32425821 DOI: 10.3389/fpsyt.2020.00286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 2020;28:23-33. [DOI: 10.1007/s00520-019-05016-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
20 Chey WD, Whelan K. Dietary guidelines for irritable bowel syndrome are important for gastroenterologists, dietitians and people with irritable bowel syndrome. J Hum Nutr Diet 2016;29:547-8. [PMID: 27599641 DOI: 10.1111/jhn.12413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Spillebout A, Dechelotte P, Ladner J, Tavolacci M. Mental health among university students with eating disorders and irritable bowel syndrome in France. Revue d'Épidémiologie et de Santé Publique 2019;67:295-301. [DOI: 10.1016/j.respe.2019.04.056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
22 Rossi G, Gioacchini G, Pengo G, Suchodolski JS, Jergens AE, Allenspach K, Gavazza A, Scarpona S, Berardi S, Galosi L, Bassotti G, Cerquetella M. Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes. Neurogastroenterol Motil 2020;32:e13717. [PMID: 31495983 DOI: 10.1111/nmo.13717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zhou C, Zhao E, Li Y, Jia Y, Li F. Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials. Neurogastroenterol Motil 2019;31:e13461. [PMID: 30232834 DOI: 10.1111/nmo.13461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
24 Kamiński M, Skonieczna-Żydecka K, Łoniewski I, Koulaouzidis A, Marlicz W. Are probiotics useful in the treatment of chronic idiopathic constipation in adults? A review of existing systematic reviews, meta-analyses, and recommendations. Prz Gastroenterol 2020;15:103-18. [PMID: 32550942 DOI: 10.5114/pg.2019.86747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Wongtrakul W, Charoenngam N, Ungprasert P. The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. Osteoporos Int 2020;31:1049-57. [PMID: 32008157 DOI: 10.1007/s00198-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM. Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13244. [DOI: 10.1111/nmo.13244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
27 Mearin F, Caballero AM, Serra J, Brotons C, Tantiñà A, Fort E, Martínez-Cerezo FJ, Perelló A, Sánchez-Antolín G, Rey E, Angós Musgo R, Berdier R, Gómez-Rodríguez B, Clavé P, García-Alonso M, Torán-Monserrat P, Tack J. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. Gastroenterol Hepatol 2019;42:141-9. [PMID: 30612850 DOI: 10.1016/j.gastrohep.2018.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Drossman DA. Katie: The Physician’s Perspective of a Young Woman’s Illness Experience. American Journal of Gastroenterology 2017;112:525-7. [DOI: 10.1038/ajg.2017.23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Brenner DM, Fogel R, Dorn SD, Krause R, Eng P, Kirshoff R, Nguyen A, Crozier RA, Magnus L, Griffin PH. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials: . American Journal of Gastroenterology 2018;113:735-45. [DOI: 10.1038/s41395-018-0026-7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 19.3] [Reference Citation Analysis]
30 Staudacher HM, Ralph FS, Irving PM, Whelan K, Lomer MC. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet. Journal of the Academy of Nutrition and Dietetics 2020;120:535-47. [DOI: 10.1016/j.jand.2019.01.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 29.0] [Reference Citation Analysis]
31 Linedale EC, Mikocka-walus A, Vincent AD, Gibson PR, Andrews JM. Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial. Neurogastroenterol Motil 2018;30:e13243. [DOI: 10.1111/nmo.13243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
32 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 21.5] [Reference Citation Analysis]
33 Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019;25:1185-96. [PMID: 30886502 DOI: 10.3748/wjg.v25.i10.1185] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
34 Lee J, Sung WS, Kim EJ, Kim YW. Xiaoyao-san, a traditional Chinese herbal formula, for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24019. [PMID: 33725813 DOI: 10.1097/MD.0000000000024019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wen Q, Liu KJ, Cui BT, Li P, Wu X, Zhong M, Wei L, Tu H, Yuan Y, Lin D, Hsu WH, Wu DC, Yin H, Zhang FM. Impact of cap-assisted colonoscopy during transendoscopic enteral tubing: A randomized controlled trial. World J Gastroenterol 2020;26:6098-110. [PMID: 33132658 DOI: 10.3748/wjg.v26.i39.6098] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kamal A, Pimentel M. Influence of Dietary Restriction on Irritable Bowel Syndrome. Am J Gastroenterol 2019;114:212-20. [PMID: 30315281 DOI: 10.1038/s41395-018-0241-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
37 Kosako M, Akiho H, Miwa H, Kanazawa M, Fukudo S. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey. Biopsychosoc Med 2018;12:18. [PMID: 30534195 DOI: 10.1186/s13030-018-0137-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
38 Cifre S, Gozalbo M, Ortiz V, Soriano JM, Merino JF, Trelis M. Blastocystis subtypes and their association with Irritable Bowel Syndrome. Med Hypotheses 2018;116:4-9. [PMID: 29857906 DOI: 10.1016/j.mehy.2018.04.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
39 Vakil N. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutr Clin Pract 2018;33:468-75. [PMID: 29870082 DOI: 10.1002/ncp.10108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
40 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017;23:6788-801. [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
41 Buselli R, Veltri A, Corsi M, Marino R, Necciari G, Baldanzi S, Chiumiento M, Del Lupo E, Foddis R, Caldi F, Lambiase C, Pancetti A, Marchi S, Guglielmi G, Bellini M. Irritable Bowel Syndrome prevalence and work ability in a sample of healthcare workers exposed to occupational stress. J Psychosom Res 2021;148:110566. [PMID: 34246982 DOI: 10.1016/j.jpsychores.2021.110566] [Reference Citation Analysis]
42 Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 5] [Article Influence: 42.0] [Reference Citation Analysis]
43 Farmer AD, Wood E, Ruffle JK. An approach to the care of patients with irritable bowel syndrome. CMAJ 2020;192:E275-82. [PMID: 32179536 DOI: 10.1503/cmaj.190716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Yan B, Jiang H, Cao J, Liu Y, Liu X, Ha L, Li T, Wang F, Liu C. The effectiveness of acupoint herbal patching for functional constipation: Protocol for a meta-analysis and data mining. Medicine (Baltimore) 2021;100:e24029. [PMID: 33466147 DOI: 10.1097/MD.0000000000024029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology 2019;4:831-44. [DOI: 10.1016/s2468-1253(19)30246-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 16.0] [Reference Citation Analysis]
46 Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M. Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study. Clinical Gastroenterology and Hepatology 2018;16:1252-1259.e5. [DOI: 10.1016/j.cgh.2018.02.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
47 Di Stefano M, Pesatori EV, Manfredi GF, De Amici M, Grandi G, Gabriele A, Iozzi D, Di Fede G. Non-Celiac Gluten Sensitivity in patients with severe abdominal pain and bloating: The accuracy of ALCAT 5. Clin Nutr ESPEN 2018;28:127-31. [PMID: 30390869 DOI: 10.1016/j.clnesp.2018.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lindberg G. Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome. Best Pract Res Clin Gastroenterol. 2019;40-41:101635. [PMID: 31594655 DOI: 10.1016/j.bpg.2019.101635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. Gastroenterology. 2018;155:1753-1763. [PMID: 30144426 DOI: 10.1053/j.gastro.2018.08.021] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 22.0] [Reference Citation Analysis]
50 Ohkuma T, Iwase M, Fujii H, Ide H, Komorita Y, Yoshinari M, Oku Y, Higashi T, Nakamura U, Kitazono T. Defecation frequency and glycemic control in patients with diabetes: The Fukuoka Diabetes Registry. J Diabetes Complications 2021;35:107751. [PMID: 33127269 DOI: 10.1016/j.jdiacomp.2020.107751] [Reference Citation Analysis]
51 Abe T, Kunimoto M, Hachiro Y, Ohara K, Inagaki M, Murakami M. Rectosigmoid Localization of Radiopaque Markers for Identifying Defecation Disorders in Patients With Chronic Constipation: A Retrospective Cohort Study. J Neurogastroenterol Motil 2021;27:419-25. [PMID: 34210907 DOI: 10.5056/jnm20204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Fukudo S, Nakamura M, Hamatani T, Kazumori K, Miwa H. Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2021;19:538-546.e8. [DOI: 10.1016/j.cgh.2020.03.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
53 Cobo Dols M, Beato Zambrano C, Cabezón Gutiérrez L, Chicas Sett R, Blancas López-Barajas MI, García Navalón F, Fírvida Pérez JL, Serrano Bermúdez G, Togores Torres P, Delgado Mingorance I, Giraldo Marín A, Librán Oriol A, Paredes Lario A, Sánchez Mauriño P, Higuera Gómez O, Moreno Muñoz D, Jiménez López AJ, Huerta González I, Sanz Yagüe A, Soler López B. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis. BMJ Support Palliat Care 2021;11:25-31. [PMID: 32376758 DOI: 10.1136/bmjspcare-2020-002249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Werth BL, Fisher MJ, Williams KA, Pont LG. Chronic Constipation in the Community: A National Survey of Australian Adults. Journal of Wound, Ostomy & Continence Nursing 2020;47:259-64. [DOI: 10.1097/won.0000000000000632] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Duncan PI, Enters-Weijnen CF, Emami N, McLean P, Nunes T, Beaumont M, Crabbe R, Whelan K, Scott SM, deWit NJ, Weits T, Bergonzelli G, Grobbee DE. Short-Term Daily Intake of Polydextrose Fiber Does Not Shorten Intestinal Transit Time in Constipated Adults: A Randomized Controlled Trial. Nutrients 2018;10:E920. [PMID: 30029461 DOI: 10.3390/nu10070920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
56 Vriesman MH, Koppen IJN, Camilleri M, Di Lorenzo C, Benninga MA. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol 2020;17:21-39. [PMID: 31690829 DOI: 10.1038/s41575-019-0222-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
57 Gupta A, Basson S, Borrelli O, Lindley K, Thapar N, Saliakellis E, Curry J, Blackburn S. Surgically treated intractable constipation in children evaluated with colonic manometry. Journal of Pediatric Surgery 2020;55:265-8. [DOI: 10.1016/j.jpedsurg.2019.10.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Bellini M, Tonarelli S, Barracca F, Morganti R, Pancetti A, Bertani L, de Bortoli N, Costa F, Mosca M, Marchi S, Rossi A. A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up. Nutrients 2020;12:E2360. [PMID: 32784614 DOI: 10.3390/nu12082360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
59 Hammer J, Führer M. Clinical characteristics of functional dyspepsia depending on chemosensitivity to capsaicin. Neurogastroenterol Motil 2017;29:1-12. [PMID: 28547912 DOI: 10.1111/nmo.13103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
60 Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology 2019;4:20-31. [DOI: 10.1016/s2468-1253(18)30310-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 16.5] [Reference Citation Analysis]
61 Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 2018;30:e13275. [DOI: 10.1111/nmo.13275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
62 Downs IA, Aroniadis OC, Kelly L, Brandt LJ. Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease. J Clin Gastroenterol 2017;51:869-77. [PMID: 28885302 DOI: 10.1097/MCG.0000000000000924] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
63 Chey WD. Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:xv-xvi. [PMID: 34304798 DOI: 10.1016/j.gtc.2021.04.007] [Reference Citation Analysis]
64 Remes-Troche JM, Coss-Adame E, Lopéz-Colombo A, Amieva-Balmori M, Carmona Sánchez R, Charúa Guindic L, Flores Rendón R, Gómez Escudero O, González Martínez M, Icaza Chávez ME, Morales Arámbula M, Schmulson M, Tamayo de la Cuesta JL, Valdovinos MÁ, Vázquez Elizondo G. The Mexican consensus on chronic constipation. Rev Gastroenterol Mex (Engl Ed) 2018;83:168-89. [PMID: 29555103 DOI: 10.1016/j.rgmx.2017.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Linedale EC, Andrews JM. Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Med J Aust. 2017;207:309-315. [PMID: 28954618 DOI: 10.5694/mja17.00457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
66 Staller K, Cash BD. Myths and Misconceptions About Constipation: A New View for the 2020s. Am J Gastroenterol 2020;115:1741-5. [DOI: 10.14309/ajg.0000000000000947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Salvador F, Lobo B, Goterris L, Alonso-Cotoner C, Santos J, Sulleiro E, Bailo B, Carmena D, Sánchez-Montalvá A, Bosch-Nicolau P, Espinosa-Pereiro J, Fuentes I, Molina I. Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established? Biology (Basel) 2021;10:340. [PMID: 33921803 DOI: 10.3390/biology10040340] [Reference Citation Analysis]
68 Lindfors P, Axelsson E, Engstrand K, Störsrud S, Jerlstad P, Törnblom H, Ljótsson B, Simrén M, Ringström G. Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial. Clin Gastroenterol Hepatol 2021;19:743-751.e1. [PMID: 32289541 DOI: 10.1016/j.cgh.2020.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 32.0] [Reference Citation Analysis]
70 Kumral D, Syed S. Celiac Disease Screening for High-Risk Groups: Are We Doing It Right? Dig Dis Sci 2020;65:2187-95. [DOI: 10.1007/s10620-020-06352-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Mitchell H, Porter J, Gibson PR, Barrett J, Garg M. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment Pharmacol Ther. 2019;49:124-139. [PMID: 30589971 DOI: 10.1111/apt.15079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 18.5] [Reference Citation Analysis]
72 Aziz I, Simrén M. The overlap between irritable bowel syndrome and organic gastrointestinal diseases. The Lancet Gastroenterology & Hepatology 2021;6:139-48. [DOI: 10.1016/s2468-1253(20)30212-0] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
73 Cobo Dols M, Beato Zambrano C, Cabezón-Gutiérrez L, Chicas-Sett R, Blancas López-Barajas MI, García Navalón FJ, Fírvida Pérez JL, Serrano Bermúdez G, Togores Torres P, Delgado Mingorance I, Giraldo Marín A, Librán Oriol A, Paredes Lario A, Sánchez Mauriño P, Higuera Gómez O, Moreno Muñoz D, Huerta González I, Sanz-Yagüe A, Soler López B. One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study. BMJ Support Palliat Care 2021:bmjspcare-2020-002816. [PMID: 33707299 DOI: 10.1136/bmjspcare-2020-002816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Dionne JC, Johnstone J, Smith O, Rose L, Oczkowski S, Arabi Y, Duan EH, Lauzier F, Alhazzani W, Alam N, Zytaruk N, Campisi J, Cook DJ. Content analysis of bowel protocols for the management of constipation in adult critically ill patients. J Crit Care 2020;58:98-104. [PMID: 32408108 DOI: 10.1016/j.jcrc.2020.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Black CJ, Craig O, Gracie DJ, Ford AC. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut 2021;70:1110-6. [PMID: 32973070 DOI: 10.1136/gutjnl-2020-322519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
76 Siah KTH, Gwee KA. Rome IV Exploratory Model Closely Resemble Asian Functional Gastrointestinal Disorder Symptom Clusters. Clin Gastroenterol Hepatol 2019;17:1002. [PMID: 30902227 DOI: 10.1016/j.cgh.2018.09.027] [Reference Citation Analysis]
77 Defrees DN, Bailey J. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Prim Care 2017;44:655-71. [PMID: 29132527 DOI: 10.1016/j.pop.2017.07.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 9.8] [Reference Citation Analysis]
78 Quigley EMM. The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS). J Clin Med 2018;7:E6. [PMID: 29301380 DOI: 10.3390/jcm7010006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
79 Panarese A, Pesce F, Porcelli P, Riezzo G, Iacovazzi PA, Leone CM, De Carne M, Rinaldi CM, Shahini E. Chronic functional constipation is strongly linked to vitamin D deficiency. World J Gastroenterol 2019;25:1729-40. [PMID: 31011257 DOI: 10.3748/wjg.v25.i14.1729] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
80 Saidi K, Nilholm C, Roth B, Ohlsson B. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr Res 2021;86:23-36. [PMID: 33450656 DOI: 10.1016/j.nutres.2020.12.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150:1257-1261. [PMID: 27147121 DOI: 10.1053/j.gastro.2016.03.035] [Cited by in Crossref: 462] [Cited by in F6Publishing: 305] [Article Influence: 154.0] [Reference Citation Analysis]
82 Shin A, Xu H, Imperiale TF. Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults. BMJ Open Gastroenterol 2019;6:e000322. [PMID: 31523443 DOI: 10.1136/bmjgast-2019-000322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Mehta V, Mehta A, Patel S, Irastorza L, Rizvi SA, Abomoelak B, Mehta N, Mehta D. Efficacy of Short Course of Preksha Dhyana for Functional Abdominal Pain Disorder in a Busy Pediatric Clinic. Front Pediatr 2021;9:646686. [PMID: 34113586 DOI: 10.3389/fped.2021.646686] [Reference Citation Analysis]
84 Seddighnia A, Tadayon Najafabadi B, Ghamari K, Noorbala AA, Ebrahimi Daryani N, Kashani L, Akhondzadeh S. Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 2020;45:97-104. [PMID: 31486103 DOI: 10.1111/jcpt.13032] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Goodoory VC, Mikocka-Walus A, Yiannakou Y, Houghton LA, Black CJ, Ford AC. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:1485-94. [PMID: 33840729 DOI: 10.14309/ajg.0000000000001247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 2020;69:1441-51. [DOI: 10.1136/gutjnl-2020-321191] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 34.0] [Reference Citation Analysis]
87 Gwee KA, Gonlachanvit S, Ghoshal UC, Chua ASB, Miwa H, Wu J, Bak YT, Lee OY, Lu CL, Park H, Chen M, Syam AF, Abraham P, Sollano J, Chang CS, Suzuki H, Fang X, Fukudo S, Choi MG, Hou X, Hongo M. Second Asian Consensus on Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2019;25:343-362. [PMID: 31327218 DOI: 10.5056/jnm19041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
88 Floch MH. The Role of Prebiotics and Probiotics in Gastrointestinal Disease. Gastroenterol Clin North Am 2018;47:179-91. [PMID: 29413011 DOI: 10.1016/j.gtc.2017.09.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
89 Lan J, Wang K, Chen G, Cao G, Yang C. Effects of inulin and isomalto-oligosaccharide on diphenoxylate-induced constipation, gastrointestinal motility-related hormones, short-chain fatty acids, and the intestinal flora in rats. Food Funct 2020;11:9216-25. [PMID: 33030479 DOI: 10.1039/d0fo00865f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
90 Prospero L, Riezzo G, Linsalata M, Orlando A, D'Attoma B, Russo F. Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier. Nutrients 2021;13:2469. [PMID: 34371976 DOI: 10.3390/nu13072469] [Reference Citation Analysis]
91 Jun H, Ko SJ, Kim K, Kim J, Jung HS, Park JW. Herbal medicine for irritable bowel syndrome: An overview of systematic reviews protocol. Medicine (Baltimore) 2021;100:e26364. [PMID: 34128890 DOI: 10.1097/MD.0000000000026364] [Reference Citation Analysis]
92 Brunkwall L, Ericson U, Nilsson PM, Orho-Melander M, Ohlsson B. Self-reported bowel symptoms are associated with differences in overall gut microbiota composition and enrichment of Blautia in a population-based cohort. J Gastroenterol Hepatol 2021;36:174-80. [PMID: 32428346 DOI: 10.1111/jgh.15104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Park SY, Khemani D, Nelson AD, Eckert D, Camilleri M. Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation. Clin Gastroenterol Hepatol 2017;15:543-552.e4. [PMID: 27856363 DOI: 10.1016/j.cgh.2016.11.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
94 Li X, Li B, Zhang J, Chen T, Wu H, Shi X, Ma J, Qin J, Tang X, Wang F. Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24361. [PMID: 33530231 DOI: 10.1097/MD.0000000000024361] [Reference Citation Analysis]
95 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 47] [Article Influence: 17.5] [Reference Citation Analysis]
96 Mori S, Tomita T, Fujimura K, Asano H, Ogawa T, Yamasaki T, Kondo T, Kono T, Tozawa K, Oshima T, Fukui H, Kimura T, Watari J, Miwa H. A Randomized Double-blind Placebo-controlled Trial on the Effect of Magnesium Oxide in Patients With Chronic Constipation. J Neurogastroenterol Motil 2019;25:563-75. [PMID: 31587548 DOI: 10.5056/jnm18194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
97 Pinto CFCS, Oliveira PDCM, Fernandes OMFSDO, Padilha JMDSC, Machado PAP, Ribeiro ALA, Ramos JLN. Nonpharmacological Clinical Effective Interventions in Constipation: A Systematic Review. Journal of Nursing Scholarship 2020;52:261-9. [DOI: 10.1111/jnu.12555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Dimidi E, Rossi M, Whelan K. Irritable bowel syndrome and diet: where are we in 2018? Current Opinion in Clinical Nutrition & Metabolic Care 2017;20:456-63. [DOI: 10.1097/mco.0000000000000416] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
99 Asano T, Takenaga M. Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea? J Clin Med 2017;6:E104. [PMID: 29099770 DOI: 10.3390/jcm6110104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
100 Kim JH, Lin E, Pimentel M. Biomarkers of Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:20-6. [PMID: 27817184 DOI: 10.5056/jnm16135] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
101 Gallotta S, Bruno V, Catapano S, Mobilio N, Ciacci C, Iovino P. High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity? World J Gastroenterol 2017;23:103-9. [PMID: 28104985 DOI: 10.3748/wjg.v23.i1.103] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
102 Caldwell PHY, Lim M, Nankivell G. An interprofessional approach to managing children with treatment-resistant enuresis: an educational review. Pediatr Nephrol 2018;33:1663-70. [DOI: 10.1007/s00467-017-3830-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
103 Meerveld BG, Johnson AC. Mechanisms of Stress-induced Visceral Pain. J Neurogastroenterol Motil 2018;24:7-18. [PMID: 29291604 DOI: 10.5056/jnm17137] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
104 Camilleri M, Halawi H, Oduyebo I. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we? Expert Rev Gastroenterol Hepatol 2017;11:303-16. [PMID: 28128666 DOI: 10.1080/17474124.2017.1288096] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
105 Dale HF, Jensen C, Hausken T, Valeur J, Hoff DAL, Lied GA. Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients 2019;11:E1635. [PMID: 31319590 DOI: 10.3390/nu11071635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
106 Low EXS, Mandhari MNKA, Herndon CC, Loo EXL, Tham EH, Siah KTH. Parental, Perinatal, and Childhood Risk Factors for Development of Irritable Bowel Syndrome: A Systematic Review. J Neurogastroenterol Motil 2020;26:437-46. [PMID: 32989183 DOI: 10.5056/jnm20109] [Reference Citation Analysis]
107 Richardson DP, Ansell J, Drummond LN. The nutritional and health attributes of kiwifruit: a review. Eur J Nutr 2018;57:2659-76. [PMID: 29470689 DOI: 10.1007/s00394-018-1627-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 33] [Article Influence: 18.3] [Reference Citation Analysis]
108 Misawa N, Higurashi T, Takatsu T, Iwaki M, Kobayashi T, Yoshihara T, Ashikari K, Kessoku T, Fuyuki A, Matsuura T, Ohkubo H, Usuda H, Wada K, Naritaka N, Takei H, Nittono H, Matsumoto M, Honda A, Nakajima A, Camilleri M. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota. Aliment Pharmacol Ther 2020;52:821-8. [PMID: 32687674 DOI: 10.1111/apt.15950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
109 Ghoshal UC. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment. J Gastroenterol Hepatol 2020;35:712-21. [PMID: 32162356 DOI: 10.1111/jgh.15032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
110 Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Gastroenterology 2020;158:123-36. [PMID: 31470006 DOI: 10.1053/j.gastro.2019.08.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
111 Gustafsson M, Lämås K, Isaksson U, Sandman PO, Lövheim H. Constipation and laxative use among people living in nursing homes in 2007 and 2013. BMC Geriatr 2019;19:38. [PMID: 30736737 DOI: 10.1186/s12877-019-1054-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
112 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. European Journal of Pharmacology 2019;852:198-206. [DOI: 10.1016/j.ejphar.2019.03.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
113 Nee J, Rangan V, Lembo A. Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract. Neurogastroenterol Motil 2018;30:e13367. [DOI: 10.1111/nmo.13367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
114 Currò D. Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2021;:1-12. [PMID: 33908323 DOI: 10.1080/17474124.2021.1924057] [Reference Citation Analysis]
115 Alzahrani MA, Alshamrani AS, Ahmasani IM, Alahmari FS, Asiri AH, Alshehri AM, Alsamghan AS, Awadalla NJ. Coronavirus disease 2019 pandemic stress and its effects on irritable bowel syndrome patients in Saudi Arabia. Medicine (Baltimore) 2020;99:e23711. [PMID: 33371119 DOI: 10.1097/MD.0000000000023711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Månsson S, Ekberg O, Ohlsson B. Motility index measured by magnetic resonance enterography is associated with sex and mural thickness. World J Gastroenterol 2020;26:5484-97. [PMID: 33024399 DOI: 10.3748/wjg.v26.i36.5484] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Jones MP, Faresjö Å, Beath A, Faresjö T, Ludvigsson J. Abdominal Pain in Children Develops With Age and Increases With Psychosocial Factors. Clin Gastroenterol Hepatol 2020;18:360-367.e1. [PMID: 31009796 DOI: 10.1016/j.cgh.2019.04.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
118 Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M. Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
119 Olaisen M, Flatberg A, Granlund AVB, Røyset ES, Martinsen TC, Sandvik AK, Fossmark R. Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease. Inflamm Bowel Dis 2021;27:12-24. [PMID: 32448900 DOI: 10.1093/ibd/izaa107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
120 Lee SM, Kim N, Yoon H, Kim YS, Choi SI, Park JH, Lee DH. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients. Gut Liver 2021;15:253-61. [PMID: 32457278 DOI: 10.5009/gnl19379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
121 Kowalski K, Mulak A. Brain-Gut-Microbiota Axis in Alzheimer's Disease. J Neurogastroenterol Motil 2019;25:48-60. [PMID: 30646475 DOI: 10.5056/jnm18087] [Cited by in Crossref: 212] [Cited by in F6Publishing: 158] [Article Influence: 106.0] [Reference Citation Analysis]
122 Wang C, Zhang X, Wang D, Shi B, Sun G, Zhang B, Zou L. Tuina for functional constipation: A protocol for the systematic review of randomized clinical trials. Medicine (Baltimore) 2019;98:e14775. [PMID: 30855485 DOI: 10.1097/MD.0000000000014775] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Barberio B, Yiannakou Y, Houghton LA, Black CJ, Savarino EV, Ford AC. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00445-6. [PMID: 33839276 DOI: 10.1016/j.cgh.2021.04.011] [Reference Citation Analysis]
124 Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology 2020;158:1262-1273.e3. [PMID: 31917991 DOI: 10.1053/j.gastro.2019.12.021] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 85.0] [Reference Citation Analysis]
125 Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med 2020;9:E685. [PMID: 32143424 DOI: 10.3390/jcm9030685] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
126 Fumita S, Imai H, Harada T, Noriyuki T, Gamoh M, Akashi Y, Sato H, Kizawa Y, Tokoro A. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer. J Pain Symptom Manage 2020;59:1043-1051.e2. [PMID: 31805362 DOI: 10.1016/j.jpainsymman.2019.11.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Tack J, Drossman DA. What's new in Rome IV? Neurogastroenterol Motil 2017;29. [PMID: 28303651 DOI: 10.1111/nmo.13053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
128 Estremera-Arevalo F, Barcelo M, Serrano B, Rey E. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis. World J Gastroenterol 2019;25:837-47. [PMID: 30809083 DOI: 10.3748/wjg.v25.i7.837] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Cheyette BNR, Cheyette SNR. Acute exacerbation of irritable bowel syndrome prevented by prn oral triptan. Clin J Gastroenterol 2016;9:375-8. [DOI: 10.1007/s12328-016-0689-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
130 Ghoshal UC. Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros. J Neurogastroenterol Motil. 2017;23:334-340. [PMID: 28672432 DOI: 10.5056/jnm17020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
131 Zhang X, Tian H, Gu L, Nie Y, Ding C, Ge X, Yang B, Gong J, Li N. Long-term follow-up of the effects of fecal microbiota transplantation in combination with soluble dietary fiber as a therapeutic regimen in slow transit constipation. Sci China Life Sci 2018;61:779-86. [PMID: 29441452 DOI: 10.1007/s11427-017-9229-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
132 Kosako M, Akiho H, Miwa H, Kanazawa M, Fukudo S. Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey. Biopsychosoc Med 2018;12:12. [PMID: 30186363 DOI: 10.1186/s13030-018-0131-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
133 Nigam GB, Limdi JK, Vasant DH. Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease. Therap Adv Gastroenterol. 2018;11:1756284818816956. [PMID: 30574193 DOI: 10.1177/1756284818816956] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
134 Pop LL, Mureşan IA, Dumitraşcu DL. How much bloating in the irritable bowel syndrome? Rom J Intern Med 2018;56:221-6. [PMID: 29894305 DOI: 10.2478/rjim-2018-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Heidelbaugh J, Martinez de Andino N, Pineles D, Poppers DM. Diagnosing Constipation Spectrum Disorders in a Primary Care Setting. J Clin Med 2021;10:1092. [PMID: 33807888 DOI: 10.3390/jcm10051092] [Reference Citation Analysis]
136 Tack J, Camilleri M, Hale M, Morlion B, Nalamachu S, Webster L, Wild J. Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00507-3. [PMID: 33965574 DOI: 10.1016/j.cgh.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Moosavi S, Pimentel M, Wong MS, Rezaie A. Irritable Bowel Syndrome in Pregnancy. Am J Gastroenterol 2021;116:480-90. [DOI: 10.14309/ajg.0000000000001124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Chang L. How to Approach a Patient with Difficult-to-Treat IBS. Gastroenterology 2021:S0016-5085(21)03285-6. [PMID: 34331916 DOI: 10.1053/j.gastro.2021.07.034] [Reference Citation Analysis]
139 Katakami N, Harada T, Murata T, Shinozaki K, Tsutsumi M, Yokota T, Arai M, Tada Y, Narabayashi M, Boku N. Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer. J Clin Oncol 2017;35:3859-66. [PMID: 28968171 DOI: 10.1200/JCO.2017.73.0853] [Cited by in Crossref: 59] [Cited by in F6Publishing: 17] [Article Influence: 14.8] [Reference Citation Analysis]
140 Shin SY, Cha BK, Kim WS, Park JY, Kim JW, Choi CH. The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial. J Neurogastroenterol Motil 2020;26:117-27. [PMID: 31917916 DOI: 10.5056/jnm19160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
141 Ong AM. Utility of gastrointestinal ultrasound in functional gastrointestinal disorders: A narrative review. WJAM 2020;8:109-18. [DOI: 10.13105/wjma.v8.i2.109] [Reference Citation Analysis]
142 Midenfjord I, Borg A, Törnblom H, Simrén M. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:769-79. [DOI: 10.14309/ajg.0000000000001038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
143 Botschuijver S, Welting O, Levin E, Maria-Ferreira D, Koch E, Montijn RC, Seppen J, Hakvoort TBM, Schuren FHJ, de Jonge WJ, van den Wijngaard RM. Reversal of visceral hypersensitivity in rat by Menthacarin® , a proprietary combination of essential oils from peppermint and caraway, coincides with mycobiome modulation. Neurogastroenterol Motil 2018;30:e13299. [PMID: 29383802 DOI: 10.1111/nmo.13299] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
144 Whelan K, Martin LD, Staudacher HM, Lomer MCE. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 2018;31:239-55. [DOI: 10.1111/jhn.12530] [Cited by in Crossref: 97] [Cited by in F6Publishing: 63] [Article Influence: 32.3] [Reference Citation Analysis]
145 Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Aliment Pharmacol Ther 2019;49:744-58. [DOI: 10.1111/apt.15106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
146 Leylabadlo HE, Ghotaslou R, Feizabadi MM, Farajnia S, Moaddab SY, Ganbarov K, Khodadadi E, Tanomand A, Sheykhsaran E, Yousefi B, Kafil HS. The critical role of Faecalibacterium prausnitzii in human health: An overview. Microb Pathog 2020;149:104344. [PMID: 32534182 DOI: 10.1016/j.micpath.2020.104344] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
147 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13819. [PMID: 32056324 DOI: 10.1111/nmo.13819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
148 Okawa Y, Fukudo S, Sanada H. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review. Biopsychosoc Med. 2019;13:10. [PMID: 31080496 DOI: 10.1186/s13030-019-0152-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
149 Ju WJ, Zhao ZK, Chen SL, Zhou DD, Yang WN, Wen XP, Du GL. Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats. Front Pharmacol 2020;11:423. [PMID: 32317976 DOI: 10.3389/fphar.2020.00423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
150 Singh P, Surana R, Soni S, Agnihotri A, Ahuja V, Makharia GK, Staller K, Kuo B. Cross cultural comparison of constipation profiles at tertiary care centers between India and USA. Neurogastroenterol Motil 2018. [PMID: 29521026 DOI: 10.1111/nmo.13324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
151 Schiller LR. Chronic Diarrhea Evaluation in the Elderly: IBS or Something Else? Curr Gastroenterol Rep 2019;21:45. [PMID: 31346793 DOI: 10.1007/s11894-019-0714-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Dothel G, Barbaro MR, Raschi E, Barbara G, De Ponti F. Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert Opin Investig Drugs 2018;27:251-63. [PMID: 29451407 DOI: 10.1080/13543784.2018.1442434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
153 Chu NHS, Yao CK, Tan VPY. Food Therapy in Sinosphere Asia. Journal of Clinical Gastroenterology 2018;52:105-13. [DOI: 10.1097/mcg.0000000000000932] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
154 Schiller LR. Chronic constipation: new insights, better outcomes? The Lancet Gastroenterology & Hepatology 2019;4:873-82. [DOI: 10.1016/s2468-1253(19)30199-2] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
155 Pannemans J, Van den Houte K, Fischler B, Piessevaux H, Carbone F, Tack J. Prevalence and impact of self-reported painful and non-painful constipation in the general population. Neurogastroenterol Motil 2020;32:e13783. [PMID: 31975471 DOI: 10.1111/nmo.13783] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Alammar N, Stein E. Irritable Bowel Syndrome: What Treatments Really Work. Med Clin North Am. 2019;103:137-152. [PMID: 30466670 DOI: 10.1016/j.mcna.2018.08.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
157 Fernández-Montes A, de Velasco G, Aguín S, Farriols C, Guirado-Risueño M, Jerviz-Guía VG, Baeza-Nadal MV, Chicas-Sett R, Fírvida JL, García-Navalón F, Martín P, Perezagua-Marín C, Rodríguez D, Santamaría J, Saurí T, Cobo M. Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice. Curr Treat Options Oncol 2021;22:26. [PMID: 33635493 DOI: 10.1007/s11864-021-00816-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Xiao QY, Fang XC, Li XQ, Fei GJ. Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World J Gastroenterol 2020;26:2049-63. [PMID: 32536774 DOI: 10.3748/wjg.v26.i17.2049] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
159 Bennet SMP, Palsson O, Whitehead WE, Barrow DA, Törnblom H, Öhman L, Simrén M, van Tilburg MAL. Systemic cytokines are elevated in a subset of patients with irritable bowel syndrome but largely unrelated to symptom characteristics. Neurogastroenterol Motil 2018;30:e13378. [PMID: 29797382 DOI: 10.1111/nmo.13378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
160 Alaimo A, Rubert J. The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract. Int J Mol Sci 2019;20:E5277. [PMID: 31652951 DOI: 10.3390/ijms20215277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
161 Wilson B, Cox SR, Whelan K. Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation. Proc Nutr Soc 2021;80:19-28. [PMID: 32468985 DOI: 10.1017/S0029665120006990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
162 Hellström PM, Benno P. The Rome IV: Irritable bowel syndrome - A functional disorder. Best Pract Res Clin Gastroenterol 2019;40-41:101634. [PMID: 31594650 DOI: 10.1016/j.bpg.2019.101634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
163 Hon E, Gupta SK. Gastrointestinal Food Allergies and Intolerances. Gastroenterol Clin North Am 2021;50:41-57. [PMID: 33518168 DOI: 10.1016/j.gtc.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Jia M, Lu X, Wang Z, Zhao L, Zhang S. Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility. J Neurogastroenterol Motil 2018;24:479-89. [PMID: 29715711 DOI: 10.5056/jnm17093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
165 Chey WD, Sayuk GS, Bartolini W, Reasner DS, Fox SM, Bochenek W, Boinpally R, Shea E, Tripp K, Borgstein N. Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. Am J Gastroenterol 2021;116:354-61. [PMID: 33065589 DOI: 10.14309/ajg.0000000000000967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
166 Blot E, Raz M, Withall J, Link L, Rich E. The Effectiveness of a Senokot Cocktail for Postoperative Constipation. Orthop Nurs 2021;40:159-68. [PMID: 34004615 DOI: 10.1097/NOR.0000000000000756] [Reference Citation Analysis]
167 Ruffle JK, Tinkler L, Emmett C, Ford AC, Nachev P, Aziz Q, Farmer AD, Yiannakou Y. Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach. Am J Gastroenterol 2021;116:142-51. [PMID: 32868630 DOI: 10.14309/ajg.0000000000000816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
169 Polster A, Van Oudenhove L, Jones M, Öhman L, Törnblom H, Simrén M. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms. Aliment Pharmacol Ther 2017;46:529-39. [PMID: 28671338 DOI: 10.1111/apt.14207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
170 Hagiwara SI, Hasdemir B, Heyman MB, Chang L, Bhargava A. Plasma Corticotropin-Releasing Factor Receptors and B7-2⁺ Extracellular Vesicles in Blood Correlate with Irritable Bowel Syndrome Disease Severity. Cells 2019;8:E101. [PMID: 30704133 DOI: 10.3390/cells8020101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
171 Grubišić V, Perez-Medina AL, Fried DE, Sévigny J, Robson SC, Galligan JJ, Gulbransen BD. NTPDase1 and -2 are expressed by distinct cellular compartments in the mouse colon and differentially impact colonic physiology and function after DSS colitis. Am J Physiol Gastrointest Liver Physiol 2019;317:G314-32. [PMID: 31188623 DOI: 10.1152/ajpgi.00104.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
172 Goldstein RS, Cash BD. Making a Confident Diagnosis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:547-63. [PMID: 34304787 DOI: 10.1016/j.gtc.2021.03.004] [Reference Citation Analysis]
173 Palsson OS, Peery A, Seitzberg D, Amundsen ID, McConnell B, Simrén M. Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial. Clin Transl Gastroenterol 2020;11:e00276. [PMID: 33512807 DOI: 10.14309/ctg.0000000000000276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
174 Nulsen B, LeBrett W, Drossman DA, Chang L. A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome. Aliment Pharmacol Ther 2021;54:281-91. [PMID: 34148256 DOI: 10.1111/apt.16467] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Sebastián Domingo JJ. Síndrome del intestino irritable con predominio de diarrea y giardiasis: ¿es uno u otra? Gastroenterología y Hepatología 2018;41:647-8. [DOI: 10.1016/j.gastrohep.2018.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Raffa RB, Taylor R, Pergolizzi JV. Treating opioid‐induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. J Clin Pharm Ther 2019;44:361-71. [DOI: 10.1111/jcpt.12812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908-917. [PMID: 32702295 DOI: 10.1016/s2468-1253(20)30217-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 7] [Article Influence: 44.0] [Reference Citation Analysis]
178 Bouchoucha M, Deutsch D, Uong P, Mary F, Sabate JM, Benamouzig R. Characteristics of patients with overlap functional gastrointestinal disorders. J Gastroenterol Hepatol 2021;36:2171-9. [PMID: 33555092 DOI: 10.1111/jgh.15438] [Reference Citation Analysis]
179 Staudacher HM, Scholz M, Lomer MC, Ralph FS, Irving PM, Lindsay JO, Fava F, Tuohy K, Whelan K. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics. Clin Nutr 2021;40:1861-70. [PMID: 33183883 DOI: 10.1016/j.clnu.2020.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
180 Müller M, Hermes GDA, Emanuel E C, Holst JJ, Zoetendal EG, Smidt H, Troost F, Schaap FG, Damink SO, Jocken JWE, Lenaerts K, Masclee AAM, Blaak EE. Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit. Gut Microbes 2020;12:1704141. [PMID: 31983281 DOI: 10.1080/19490976.2019.1704141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
181 Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211-2235. [PMID: 29881232 DOI: 10.3748/wjg.v24.i21.2211] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
182 Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol 2018;113:1017-25. [PMID: 29880963 DOI: 10.1038/s41395-018-0074-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
183 Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:1-9. [PMID: 29358788 DOI: 10.5507/bp.2017.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
184 Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. Am J Gastroenterol 2021;116:372-81. [PMID: 33110014 DOI: 10.14309/ajg.0000000000000975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
185 Shorey S, Demutska A, Chan V, Siah KTH. Adults living with irritable bowel syndrome (IBS): A qualitative systematic review. J Psychosom Res 2021;140:110289. [PMID: 33227554 DOI: 10.1016/j.jpsychores.2020.110289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
186 Moding M, Ohlsson B. The role of fermentable carbohydrates and beverages in the symptomatology of functional gastrointestinal disease. Scand J Gastroenterol 2017;52:1224-34. [PMID: 28826271 DOI: 10.1080/00365521.2017.1365931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
187 Zeevenhooven J, Timp ML, Singendonk MM, Benninga MA, Tabbers MM. Definitions of Pediatric Functional Abdominal Pain Disorders and Outcome Measures: A Systematic Review. The Journal of Pediatrics 2019;212:52-59.e16. [DOI: 10.1016/j.jpeds.2019.04.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
188 Ortengren AR, Ramkissoon RA, Chey WD, Baker JR, Staller K, Iturrino J, Shah ED. Anorectal manometry to diagnose dyssynergic defecation: Systematic review and meta-analysis of diagnostic test accuracy. Neurogastroenterol Motil 2021;:e14137. [PMID: 33772969 DOI: 10.1111/nmo.14137] [Reference Citation Analysis]
189 Yumizaki T, Maeda M, Fujita T, Kakuyama H, Kumagai Y. A 3-Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP-6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week. Clin Pharmacol Drug Dev 2020;9:353-65. [PMID: 31464087 DOI: 10.1002/cpdd.731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
190 Ohlsson B, Orho-Melander M, Nilsson PM. Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations. Int J Mol Sci 2017;18:E582. [PMID: 28282855 DOI: 10.3390/ijms18030582] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 10.8] [Reference Citation Analysis]
191 Ikee R, Yano K, Tsuru T. Constipation in chronic kidney disease: it is time to reconsider. Ren Replace Ther 2019;5. [DOI: 10.1186/s41100-019-0246-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
192 Brenner DM, Sayuk GS. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea. Adv Ther 2020;37:83-96. [DOI: 10.1007/s12325-019-01116-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
193 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor: Stress and visceral hypersensitivity. Journal of Gastroenterology and Hepatology 2017;32:1958-65. [DOI: 10.1111/jgh.13787] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
194 Menees SB, Franklin H, Chey WD. Evaluation of Plecanatide for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation in Patients 65 Years or Older. Clinical Therapeutics 2020;42:1406-1414.e4. [DOI: 10.1016/j.clinthera.2020.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Sadeghi A, Biglari M, Nasseri Moghaddam S. Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East J Dig Dis 2019;11:69-75. [PMID: 31380002 DOI: 10.15171/mejdd.2019.130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
196 Sirri L, Grandi S, Tossani E. Smoking in Irritable Bowel Syndrome: A Systematic Review. Journal of Dual Diagnosis 2017;13:184-200. [DOI: 10.1080/15504263.2017.1322226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
197 Curtin B, Jimenez E, Rao SSC. Clinical Evaluation of a Patient With Symptoms of Colonic or Anorectal Motility Disorders. J Neurogastroenterol Motil 2020;26:423-36. [PMID: 32989182 DOI: 10.5056/jnm20012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
198 Weaver KR, Boulineaux CM, Robinson JM, Butler K, Heitkemper MM, Henderson WA. Sex Hormones, BDNF, Leptin, and TGF-β1 in Females With IBS: A Pilot Investigation. Biol Res Nurs 2021;23:231-7. [PMID: 32806924 DOI: 10.1177/1099800420948589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, Lim HC, Shin JE, Kim SE, Cho DH, Kim JH, Kim HJ; Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil. 2018;24:197-215. [PMID: 29605976 DOI: 10.5056/jnm17145] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
200 Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2019;25:269-281. [PMID: 30670915 DOI: 10.3748/wjg.v25.i2.269] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
201 Moezi P, Salehi A, Molavi H, Poustchi H, Gandomkar A, Imanieh MH, Malekzadeh R. Prevalence of Chronic Constipation and Its Associated Factors in Pars Cohort Study: A Study of 9000 Adults in Southern Iran. Middle East J Dig Dis. 2018;10:75-83. [PMID: 30013755 DOI: 10.15171/mejdd.2018.94] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
202 Mearin F, Ciriza C, Mínguez M, Rey E, Mascort J, Peña E, Cañones P, Júdez J. Guía de práctica clínica del síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: tratamiento. (Parte 2 de 2). SEMERGEN - Medicina de Familia 2017;43:123-40. [DOI: 10.1016/j.semerg.2017.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Colomier E, Algera J, Melchior C. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front Pharmacol 2020;11:629026. [PMID: 33679391 DOI: 10.3389/fphar.2020.629026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Martinez de Andino N. Current treatment paradigm and landscape for the management of chronic idiopathic constipation in adults: Focus on plecanatide. J Am Assoc Nurse Pract 2018;30:412-20. [PMID: 29979299 DOI: 10.1097/JXX.0000000000000090] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Chuah KH, Beh KH, Mahamad Rappek NA, Mahadeva S. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care. J Dig Dis 2021;22:159-66. [PMID: 33595169 DOI: 10.1111/1751-2980.12975] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Black CJ, Yiannakou Y, Houghton LA, Shuweihdi F, West R, Guthrie E, Ford AC. Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13872] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
207 Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. The Lancet 2020;396:1664-74. [DOI: 10.1016/s0140-6736(20)32115-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 19.0] [Reference Citation Analysis]
208 Zhou Q, Verne GN. Are the Rome Criteria a Sound Standard for Gastrointestinal Disorders Worldwide? Gastroenterology 2020;158:1212-4. [PMID: 32061864 DOI: 10.1053/j.gastro.2020.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Mearin F. Irritable Bowel Syndrome: Pain in Spain. American Journal of Gastroenterology 2017;112:1768-9. [DOI: 10.1038/ajg.2017.429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
210 Pichetshote N, Pimentel M. An Approach to the Patient With Chronic Undiagnosed Abdominal Pain. Am J Gastroenterol 2019;114:726-32. [DOI: 10.14309/ajg.0000000000000130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
211 Craig O. New therapies in Irritable Bowel Syndrome: what works and when. Current Opinion in Gastroenterology 2018;34:50-6. [DOI: 10.1097/mog.0000000000000411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
212 Juza R, Vlcek P, Mezeiova E, Musilek K, Soukup O, Korabecny J. Recent advances with 5-HT3 modulators for neuropsychiatric and gastrointestinal disorders. Med Res Rev 2020;40:1593-678. [PMID: 32115745 DOI: 10.1002/med.21666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
213 Prichard D, Norton C, Bharucha AE. Management of opioid-induced constipation. British Journal of Nursing 2016;25:S4-S11. [DOI: 10.12968/bjon.2016.25.10.s4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 3.8] [Reference Citation Analysis]
214 Chang L, Di Lorenzo C, Farrugia G, Hamilton FA, Mawe GM, Pasricha PJ, Wiley JW. Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research. Gastroenterology. 2018;154:723-735. [PMID: 29288656 DOI: 10.1053/j.gastro.2017.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
215 Hagan M, Hayee BH, Rodriguez-Mateos A. (Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review. Molecules 2021;26:1843. [PMID: 33805938 DOI: 10.3390/molecules26071843] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
216 Chen Y, Wu H, Wu S, Lu N, Wang Y, Liu H, Dong L, Liu T, Shen X. Parasutterella , in association with irritable bowel syndrome and intestinal chronic inflammation: Parasutterella may be related with IBS. Journal of Gastroenterology and Hepatology 2018;33:1844-52. [DOI: 10.1111/jgh.14281] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 22.0] [Reference Citation Analysis]
217 Chi Y, Li C, Wu LH, Wang HH. The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 2020;55:762-8. [PMID: 32493087 DOI: 10.1080/00365521.2020.1774925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
218 Peihong M, Tao Y, Zhaoxuan H, Sha Y, Li C, Kunnan X, Jingwen C, Likai H, Yuke T, Yuyi G, Fumin W, Zilei T, Ruirui S, Fang Z. Alterations of White Matter Network Properties in Patients With Functional Constipation. Front Neurol 2021;12:627130. [PMID: 33841301 DOI: 10.3389/fneur.2021.627130] [Reference Citation Analysis]
219 De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Adv Ther 2021;38:3589-621. [PMID: 34086265 DOI: 10.1007/s12325-021-01766-y] [Reference Citation Analysis]
220 Major GAD, Gunn D. Chronic diarrhoea in adults: what not to miss. Curr Opin Gastroenterol 2019;35:206-12. [PMID: 30883385 DOI: 10.1097/MOG.0000000000000516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
221 Elbadawi M, Ammar RM, Aziz-Kalbhenn H, Rabini S, Klauck SM, Dawood M, Saeed MEM, Kampf CJ, Efferth T. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. Phytomedicine 2021;88:153589. [PMID: 34111617 DOI: 10.1016/j.phymed.2021.153589] [Reference Citation Analysis]
222 Seong G, Lee S, Min YW, Jang YS, Kim HS, Kim EJ, Park SY, Kim CH, Chang DK. Effect of Heat-killed Lactobacillus casei DKGF7 on a Rat Model of Irritable Bowel Syndrome. Nutrients 2021;13:568. [PMID: 33572194 DOI: 10.3390/nu13020568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Jagielski CH, Riehl ME. Behavioral Strategies for Irritable Bowel Syndrome: Brain-Gut or Gut-Brain? Gastroenterol Clin North Am 2021;50:581-93. [PMID: 34304789 DOI: 10.1016/j.gtc.2021.03.006] [Reference Citation Analysis]
224 Canakis A, Haroon M, Weber HC. Irritable bowel syndrome and gut microbiota. Current Opinion in Endocrinology, Diabetes & Obesity 2020;27:28-35. [DOI: 10.1097/med.0000000000000523] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
225 Dupont C, Hébert G. Magnesium Sulfate-Rich Natural Mineral Waters in the Treatment of Functional Constipation-A Review. Nutrients 2020;12:E2052. [PMID: 32664341 DOI: 10.3390/nu12072052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
226 Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Curr Med Res Opin 2021;37:567-78. [PMID: 33566707 DOI: 10.1080/03007995.2021.1888705] [Reference Citation Analysis]
227 Hu Z, Li M, Yao L, Wang Y, Wang E, Yuan J, Wang F, Yang K, Bian Z, Zhong LLD. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterol 2021;21:23. [PMID: 33413140 DOI: 10.1186/s12876-020-01593-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018;113:1290-1300. [PMID: 30046155 DOI: 10.1038/s41395-018-0195-4] [Cited by in Crossref: 106] [Cited by in F6Publishing: 78] [Article Influence: 35.3] [Reference Citation Analysis]
229 Kishi K, Kamizaki M, Kaji N, Iino S, Hori M. A Close Relationship Between Networks of Interstitial Cells of Cajal and Gastrointestinal Transit In Vivo. Front Pharmacol 2020;11:587453. [PMID: 33633564 DOI: 10.3389/fphar.2020.587453] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
230 Lim J, Park H, Lee H, Lee E, Lee D, Jung HW, Jang IY. Higher frailty burden in older adults with chronic constipation. BMC Gastroenterol 2021;21:137. [PMID: 33765938 DOI: 10.1186/s12876-021-01684-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Mearin F, Rey E, Santander C. Irritable bowel syndrome: How to improve decision making in clinical practice. Med Clin (Barc) 2018;151:489-97. [PMID: 30243429 DOI: 10.1016/j.medcli.2018.06.020] [Reference Citation Analysis]
232 Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, Du Q, Liao QS, Xie R, Xu JY. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 2020;26:6141-62. [PMID: 33177790 DOI: 10.3748/wjg.v26.i40.6141] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
233 Mack A, Bobardt JS, Haß A, Nichols KB, Schmid RM, Stein-Thoeringer CK. Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort. Gut Microbes 2020;11:620-31. [PMID: 31809634 DOI: 10.1080/19490976.2019.1686322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
234 Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2021:gutjnl-2021-325214. [PMID: 34376515 DOI: 10.1136/gutjnl-2021-325214] [Reference Citation Analysis]
235 Tosto M, D'Andrea P, Salamone I, Pellegrino S, Costa S, Lucanto MC, Pallio S, Magazzu' G, Guandalini S. Functional constipation masked as irritable bowel syndrome. BMC Gastroenterol 2020;20:86. [PMID: 32252644 DOI: 10.1186/s12876-020-01244-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology 2019;157:391-402.e2. [PMID: 31022401 DOI: 10.1053/j.gastro.2019.04.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 18.5] [Reference Citation Analysis]
237 Huaman JW, Mego M, Bendezú A, Monrroy H, Samino S, Accarino A, Saperas E, Azpiroz F. Correction of Dyssynergic Defecation, but Not Fiber Supplementation, Reduces Symptoms of Functional Dyspepsia in Patients With Constipation in a Randomized Trial. Clin Gastroenterol Hepatol 2020;18:2463-2470.e1. [PMID: 31811952 DOI: 10.1016/j.cgh.2019.11.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
238 Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients 2019;11:E2048. [PMID: 31480656 DOI: 10.3390/nu11092048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
239 Yadav M, Mandeep, Shukla P. Probiotics of Diverse Origin and Their Therapeutic Applications: A Review. J Am Coll Nutr 2020;39:469-79. [PMID: 31765283 DOI: 10.1080/07315724.2019.1691957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
240 Simrén M, Törnblom H, Palsson OS, Whitehead WE. Management of the multiple symptoms of irritable bowel syndrome. Lancet Gastroenterol Hepatol 2017;2:112-22. [PMID: 28403981 DOI: 10.1016/S2468-1253(16)30116-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 8.8] [Reference Citation Analysis]
241 Poulsen JL, Mark EB, Brock C, Frøkjær JB, Krogh K, Drewes AM. Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350. J Neurogastroenterol Motil 2018;24:119-27. [PMID: 29291613 DOI: 10.5056/jnm17058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
242 Tadyon Najafabadi B, Ghamari K, Kermany Ranjabari T, Noorbala AA, Ebrahimi Daryani N, Vanaki E, Akhondzadeh S. Therapeutic effects of saffron (Crocus sativus) versus fluoxetine on Irritable Bowel Syndrome: A double-blind randomized clinical trial. Advances in Integrative Medicine 2019;6:167-73. [DOI: 10.1016/j.aimed.2019.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
243 Hawrelak JA, Wohlmuth H, Pattinson M, Myers SP, Goldenberg JZ, Harnett J, Cooley K, Van De Venter C, Reid R, Whitten DL. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Complement Ther Med 2020;48:102233. [PMID: 31987249 DOI: 10.1016/j.ctim.2019.102233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
244 Chen Y, Chu F, Lin J, Su Z, Liao M, Li T, Li Y, Johnson N, Zheng H, Ding X. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. J Ethnopharmacol 2021;275:114119. [PMID: 33862102 DOI: 10.1016/j.jep.2021.114119] [Reference Citation Analysis]
245 Nam Y, Min YS, Sohn UD. Recent advances in pharmacological research on the management of irritable bowel syndrome. Arch Pharm Res 2018;41:955-66. [PMID: 30132170 DOI: 10.1007/s12272-018-1068-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
246 Lin L, Chang L. Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence. Clinical Gastroenterology and Hepatology 2020;18:297-9. [DOI: 10.1016/j.cgh.2019.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
247 Sanchez JMS, McNally JS, Cortez MM, Hemp J, Pace LA, Clardy SL. Neuroimmunogastroenterology: At the Interface of Neuroimmunology and Gastroenterology. Front Neurol 2020;11:787. [PMID: 32849234 DOI: 10.3389/fneur.2020.00787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
248 Bellini M, Gambaccini D, Bazzichi L, Bassotti G, Mumolo MG, Fani B, Costa F, Ricchiuti A, De Bortoli N, Mosca M, Marchi S, Rossi A. Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study. Tech Coloproctol 2017;21:451-9. [PMID: 28567692 DOI: 10.1007/s10151-017-1639-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
249 Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2019;31:e13718. [PMID: 31498961 DOI: 10.1111/nmo.13718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
250 Yamada E, Tsunoda S, Mimura M, Akizuki M, Miyazawa Y, Yamazaki T, Nagano Y, Murakami R, Kitahara T, Wakasugi J, Ozawa Y, Komatsu T, Inamori M, Nagai K, Nakajima A. Positioning of Bristol Stool Form Scale type 3 in constipation treatment satisfaction: A multicenter study in Japan. J Gastroenterol Hepatol 2021;36:2125-30. [PMID: 33538361 DOI: 10.1111/jgh.15428] [Reference Citation Analysis]
251 Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome. Dig Dis Sci 2017;62:1480-5. [PMID: 28451914 DOI: 10.1007/s10620-017-4585-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
252 Dimidi E, Whelan K. Food supplements and diet as treatment options in irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13951. [PMID: 32697018 DOI: 10.1111/nmo.13951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
253 Oh SJ, Takakura W, Rezaie A. Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review. J Clin Med 2020;9:E2933. [PMID: 32932856 DOI: 10.3390/jcm9092933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
254 Bautzova T, Hockley JRF, Perez-Berezo T, Pujo J, Tranter MM, Desormeaux C, Barbaro MR, Basso L, Le Faouder P, Rolland C, Malapert P, Moqrich A, Eutamene H, Denadai-Souza A, Vergnolle N, Smith ESJ, Hughes DI, Barbara G, Dietrich G, Bulmer DC, Cenac N. 5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D. Sci Signal 2018;11:eaal2171. [PMID: 30563864 DOI: 10.1126/scisignal.aal2171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
255 Bennet SMP, Sundin J, Magnusson MK, Strid H, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation. Neurogastroenterol Motil 2018;30:e13468. [PMID: 30230134 DOI: 10.1111/nmo.13468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
256 Flach S, Scarfe G, Dragone J, Ding J, Seymour M, Pennick M, Pankratz T, Troy S, Getsy J. A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [(14)C]Prucalopride After a Single Oral Dose in Healthy Volunteers. Clin Ther 2016;38:2106-15. [PMID: 27614912 DOI: 10.1016/j.clinthera.2016.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
257 O'Keeffe M, Jansen C, Martin L, Williams M, Seamark L, Staudacher HM, Irving PM, Whelan K, Lomer MC. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil 2018;30. [PMID: 28707437 DOI: 10.1111/nmo.13154] [Cited by in Crossref: 79] [Cited by in F6Publishing: 62] [Article Influence: 19.8] [Reference Citation Analysis]
258 Harris LA, Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad Med 2017;129:872-88. [PMID: 28936910 DOI: 10.1080/00325481.2017.1383819] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
259 Passos MDCF, Moraes-Filho JP. INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES. Arq Gastroenterol. 2017;54:255-262. [PMID: 28723981 DOI: 10.1590/s0004-2803.201700000-31] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
260 Nissan B, Lachish T, Schwartz E. The effectiveness of empirical anti-parasitic treatment in returning travellers with persistent abdominal symptoms. J Travel Med 2018;25. [PMID: 29232458 DOI: 10.1093/jtm/tax083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
261 Oliviero G, Ruggiero L, D'Antonio E, Gagliardi M, Nunziata R, Di Sarno A, Abbatiello C, Di Feo E, De Vivo S, Santonicola A, Iovino P. Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress. Neurogastroenterol Motil 2021;33:e14092. [PMID: 33550640 DOI: 10.1111/nmo.14092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, Major G, O'Connor M, Sanders DS, Sinha R, Smith SC, Thomas P, Walters JRF. Guidelines for the investigation of chronic diarrhea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018;67:1380-1399. [PMID: 29653941 DOI: 10.1136/gutjnl-2017-315909] [Cited by in Crossref: 91] [Cited by in F6Publishing: 59] [Article Influence: 30.3] [Reference Citation Analysis]
263 Losurdo G, Todeschini A, Giorgio F, Piscitelli D, Giangaspero A, Ierardi E, Di Leo A. Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome. Medicina (Kaunas) 2020;56:E660. [PMID: 33260434 DOI: 10.3390/medicina56120660] [Reference Citation Analysis]
264 Krouwel M, Farley A, Greenfield S, Ismail T, Jolly K. Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics. Complement Ther Med 2021;57:102672. [PMID: 33508441 DOI: 10.1016/j.ctim.2021.102672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Snell DB, Faruqui S, Bosworth BP. A Case-Based Approach to Constipation in Primary Care. Medical Clinics of North America 2021;105:55-73. [DOI: 10.1016/j.mcna.2020.08.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Pimentel M, Cash BD, Lembo A, Wolf RA, Israel RJ, Schoenfeld P. Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity. Dig Dis Sci 2017;62:2455-63. [PMID: 28589238 DOI: 10.1007/s10620-017-4598-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
267 Demirbaş A, Elmas ÖF. The relationship between acne vulgaris and irritable bowel syndrome: A preliminary study. J Cosmet Dermatol 2021;20:316-20. [PMID: 32463985 DOI: 10.1111/jocd.13481] [Reference Citation Analysis]
268 Harada T, Imai H, Fumita S, Noriyuki T, Gamoh M, Okamoto M, Akashi Y, Kizawa Y, Tokoro A. Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer. Int J Clin Oncol 2021;26:104-10. [PMID: 33068220 DOI: 10.1007/s10147-020-01790-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Włodarczyk J, Waśniewska A, Fichna J, Dziki A, Dziki Ł, Włodarczyk M. Current Overview on Clinical Management of Chronic Constipation. J Clin Med 2021;10:1738. [PMID: 33923772 DOI: 10.3390/jcm10081738] [Reference Citation Analysis]
270 Liu R, Staller K. Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Drug Des Devel Ther 2020;14:1391-400. [PMID: 32308371 DOI: 10.2147/DDDT.S216056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Camacho M, Greenland JC, Williams-Gray CH. The Gastrointestinal Dysfunction Scale for Parkinson's Disease. Mov Disord 2021. [PMID: 34133059 DOI: 10.1002/mds.28675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Ek M, Roth B, Valentin L, Nordengren J, Ohlsson B. Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019;240:370-4. [DOI: 10.1016/j.ejogrb.2019.05.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
273 Flores V, Martínez-Lozano H, Bighelli F, Orcajo J, García-Lledó J, Alonso-Farto JC, Menchén L. Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study. BMC Gastroenterol 2021;21:56. [PMID: 33563227 DOI: 10.1186/s12876-021-01637-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Camilleri M, Brandler J. Refractory Constipation: How to Evaluate and Treat. Gastroenterol Clin North Am 2020;49:623-42. [PMID: 32718574 DOI: 10.1016/j.gtc.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Nakajima A, Seki M, Taniguchi S. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial. J Gastroenterol 2018;53:525-34. [PMID: 28840422 DOI: 10.1007/s00535-017-1383-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
276 Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
277 Lucak S, Lunsford TN, Harris LA. Evaluation and Treatment of Constipation in the Geriatric Population. Clin Geriatr Med 2021;37:85-102. [PMID: 33213776 DOI: 10.1016/j.cger.2020.08.007] [Reference Citation Analysis]
278 Camilleri M. Towards a new era with safer µ-opiate receptor analgesia. Gut 2021:gutjnl-2021-324618. [PMID: 33875448 DOI: 10.1136/gutjnl-2021-324618] [Reference Citation Analysis]
279 Liu Y, Yuan X, Li L, Lin L, Zuo X, Cong Y, Li Y. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol 2020;11:e00146. [PMID: 32352710 DOI: 10.14309/ctg.0000000000000146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
280 Bellini M, Usai-Satta P, Bove A, Bocchini R, Galeazzi F, Battaglia E, Alduini P, Buscarini E, Bassotti G; ChroCoDiTE Study Group, AIGO. Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study. BMC Gastroenterol 2017;17:11. [PMID: 28088179 DOI: 10.1186/s12876-016-0556-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
281 Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach. Neurogastroenterol Motil 2021;33:e14152. [PMID: 33835634 DOI: 10.1111/nmo.14152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Schemann M. Reizdarm und Reizmagen – Pathophysiologie und Biomarker. Gastroenterologe 2017;12:114-29. [DOI: 10.1007/s11377-017-0143-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
283 Midenfjord I, Grinsvall C, Koj P, Carnerup I, Törnblom H, Simrén M. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease. Neurogastroenterol Motil 2021;:e14156. [PMID: 33860970 DOI: 10.1111/nmo.14156] [Reference Citation Analysis]
284 Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako M, Nakagawa A, Akiho H, Kuroishi K, Johnston JM, Currie M, Ohkusa T. Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study. Neurogastroenterol Motil 2018;30:e13442. [DOI: 10.1111/nmo.13442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
285 Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019;114:21-39. [PMID: 30177784 DOI: 10.1038/s41395-018-0222-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 64] [Article Influence: 45.0] [Reference Citation Analysis]
286 Nakajima A, Shinbo K, Oota A, Kinoshita Y. Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension. J Gastroenterol 2019;54:792-803. [PMID: 31011797 DOI: 10.1007/s00535-019-01581-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
287 Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48:1044-1060. [PMID: 30294792 DOI: 10.1111/apt.15001] [Cited by in Crossref: 150] [Cited by in F6Publishing: 113] [Article Influence: 50.0] [Reference Citation Analysis]
288 Algera J, Colomier E, Simrén M. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients 2019;11:E2162. [PMID: 31505870 DOI: 10.3390/nu11092162] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
289 Calasso M, Francavilla R, Cristofori F, De Angelis M, Gobbetti M. New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study. Nutrients. 2018;10:1873. [PMID: 30513824 DOI: 10.3390/nu10121873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
290 Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021; 160: 99-114. e3. [PMID: 32294476 DOI: 10.1053/j.gastro.2020.04.014] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 112.0] [Reference Citation Analysis]
291 Jandee S, Chuensakul S, Maneerat S. No distinction in the gut microbiota between diarrhea predominant-irritable bowel syndrome and healthy subjects: matched case-control study in Thailand. Gut Pathog 2021;13:16. [PMID: 33658063 DOI: 10.1186/s13099-021-00406-8] [Reference Citation Analysis]
292 Biesiekierski JR, Jalanka J, Staudacher HM. Can Gut Microbiota Composition Predict Response to Dietary Treatments? Nutrients 2019;11:E1134. [PMID: 31121812 DOI: 10.3390/nu11051134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
293 Yamada M, Sekine M, Tatsuse T, Fujimura Y. Lifestyle, psychological stress, and incidence of adolescent constipation: results from the Toyama birth cohort study. BMC Public Health 2021;21:47. [PMID: 33407297 DOI: 10.1186/s12889-020-10044-5] [Reference Citation Analysis]
294 Ivashkin V, Poluektov Y, Kogan E, Shifrin O, Sheptulin A, Kovaleva A, Kurbatova A, Krasnov G, Poluektova E. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome. PLoS One 2021;16:e0252930. [PMID: 34115808 DOI: 10.1371/journal.pone.0252930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Roth B, Schiro DB, Ohlsson B. Diseases which cause generalized peripheral neuropathy: a systematic review. Scand J Gastroenterol 2021;56:1000-10. [PMID: 34214006 DOI: 10.1080/00365521.2021.1942542] [Reference Citation Analysis]
296 Ohlsson B. The role of smoking and alcohol behaviour in management of functional gastrointestinal disorders. Best Practice & Research Clinical Gastroenterology 2017;31:545-52. [DOI: 10.1016/j.bpg.2017.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
297 Ohkubo H, Takatsu T, Yoshihara T, Misawa N, Ashikari K, Fuyuki A, Matsuura T, Higurashi T, Yamamoto K, Matsumoto H, Odaka T, Lembo AJ, Nakajima A. Difference in Defecation Desire Between Patients With and Without Chronic Constipation: A Large-Scale Internet Survey. Clin Transl Gastroenterol 2020;11:e00230. [PMID: 32858571 DOI: 10.14309/ctg.0000000000000230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
298 Sundin J, Nordlander S, Eutamene H, Alquier‐bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
299 Iribarren C, Törnblom H, Aziz I, Magnusson MK, Sundin J, Vigsnaes LK, Amundsen ID, McConnell B, Seitzberg D, Öhman L, Simrén M. Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 2020;32:e13920. [PMID: 32536023 DOI: 10.1111/nmo.13920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
300 Vodnar DC, Călinoiu LF, Mitrea L, Precup G, Bindea M, Păcurar AM, Szabo K, Ştefănescu BE. A New Generation of Probiotic Functional Beverages Using Bioactive Compounds From Agro-Industrial Waste. Functional and Medicinal Beverages. Elsevier; 2019. pp. 483-528. [DOI: 10.1016/b978-0-12-816397-9.00015-7] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
301 Ruchkina IN, Vyaznikova AA, Indeykina LK, Degterev DA, Parfenov AI. [Multidisciplinary treatment of the patient with a severe irritable bowel syndrome]. Ter Arkh 2020;92:81-4. [PMID: 32598723 DOI: 10.26442/00403660.2020.02.000523] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
302 Major G, Murray K, Singh G, Nowak A, Hoad CL, Marciani L, Silos-Santiago A, Kurtz CB, Johnston JM, Gowland P, Spiller R. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging. Neurogastroenterol Motil. 2018;30:e13400. [PMID: 30062794 DOI: 10.1111/nmo.13400] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
303 Lacy BE, Brenner DM, Chey WD. Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00578-4. [PMID: 34048937 DOI: 10.1016/j.cgh.2021.05.040] [Reference Citation Analysis]
304 Törnblom H, Drossman DA. Psychopharmacologic Therapies for Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:655-69. [PMID: 34304793 DOI: 10.1016/j.gtc.2021.04.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Shin JE, Park KS, Nam K. Chronic Functional Constipation. Korean J Gastroenterol 2019;73:92. [DOI: 10.4166/kjg.2019.73.2.92] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
306 Brenner DM, Argoff CE, Fox SM, Bochenek W, D'Astoli P, Blakesley RE, Reasner DS, O'Dea CR, Cash BD. Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study. Pain 2020;161:1027-36. [PMID: 32310620 DOI: 10.1097/j.pain.0000000000001754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
307 Lashermes A, Boudieu L, Barbier J, Sion B, Gelot A, Barnich N, Ardid D, Carvalho FA. Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period. Gut Microbes 2018;9:26-37. [PMID: 28806140 DOI: 10.1080/19490976.2017.1361091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
308 Melchior C, Douard V, Coëffier M, Gourcerol G. Fructose and irritable bowel syndrome. Nutr Res Rev 2020;33:235-43. [PMID: 32122419 DOI: 10.1017/S0954422420000025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
309 Li N, Wang R, Ai X, Guo X, Liu J, Wang D, Sun L, Zhang R. Effect of electroacupuncture treatment on functional constipation in adults: A protocol for systematic review. Medicine (Baltimore) 2021;100:e24870. [PMID: 33725843 DOI: 10.1097/MD.0000000000024870] [Reference Citation Analysis]
310 Nordström EA, Teixeira C, Montelius C, Jeppsson B, Larsson N. Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. Benef Microbes 2021;:1-26. [PMID: 34365915 DOI: 10.3920/BM2020.0191] [Reference Citation Analysis]
311 Fukudo S, Endo Y, Hongo M, Nakajima A, Abe T, Kobayashi H, Nakata T, Nakajima T, Sameshima K, Kaku K, Shoji E, Tarumi K, Nagaoka Y, Ooshima T, Ozawa K, Majima T, Kamata S, Tada T, Ishii H, Segawa Y, Miyazaki S, Yamamoto T, Yagi Y, Sawada H, Shirota S, Otsuka S, Yamada N, Suzuki R, Kurakata H, Nakai K, Syuji Y, Usui T, Yamamura M, Oishi T, Tanaka H. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Gastroenterology & Hepatology 2018;3:603-13. [DOI: 10.1016/s2468-1253(18)30165-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 5.3] [Reference Citation Analysis]
312 Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 2021;13:2112. [PMID: 34203002 DOI: 10.3390/nu13062112] [Reference Citation Analysis]
313 Andarkhor P, Sadeghi A, Khodadoost M, Kamalinejad M, Gachkar L, Abdi S, Zargaran A. Effects of Terminalia chebula Retz. in treatment of hemorrhoids: A double – blind randomized placebo – controlled clinical trial. European Journal of Integrative Medicine 2019;30:100935. [DOI: 10.1016/j.eujim.2019.100935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Jagielski CH, Chey WD, Riehl ME. Influence of trauma on clinical outcomes, quality of life and healthcare resource utilization following psychogastroenterology intervention. J Psychosom Res 2021;146:110481. [PMID: 33867174 DOI: 10.1016/j.jpsychores.2021.110481] [Reference Citation Analysis]
315 Shiha MG, Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, Tai FWD, Afify S, Aziz I. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterol Motil 2021;33:e14121. [PMID: 33719130 DOI: 10.1111/nmo.14121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Steinsvik EK, Valeur J, Hausken T, Gilja OH. Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors. J Neurogastroenterol Motil 2020;26:96-105. [PMID: 31917915 DOI: 10.5056/jnm19072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
317 Zhang T, Wang G, Li B, Wang L, Guo J, Hu J, Du X, Hong Q, Sun J, Liu C. Effect of acupuncture for constipation after ischemic stroke: study protocol for a randomized controlled trial. Trials 2018;19:454. [PMID: 30134942 DOI: 10.1186/s13063-018-2750-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
318 Uhde M, Caio G, De Giorgio R, Green PH, Volta U, Alaedini A. Subclass Profile of IgG Antibody Response to Gluten Differentiates Nonceliac Gluten Sensitivity From Celiac Disease. Gastroenterology 2020;159:1965-1967.e2. [PMID: 32702369 DOI: 10.1053/j.gastro.2020.07.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
319 De Filippis F, Vitaglione P, Cuomo R, Berni Canani R, Ercolini D. Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine. Inflamm Bowel Dis 2018;24:2142-54. [PMID: 29668914 DOI: 10.1093/ibd/izy080] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 19.5] [Reference Citation Analysis]
320 Coughlan S, Das A, O'Herlihy E, Shanahan F, O'Toole PW, Jeffery IB. The gut virome in Irritable Bowel Syndrome differs from that of controls. Gut Microbes 2021;13:1-15. [PMID: 33602058 DOI: 10.1080/19490976.2021.1887719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
321 Nelson AD, Black CJ, Houghton LA, Lugo‐fagundo NS, Lacy BE, Ford AC. Systematic review and network meta‐analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2021;54:98-108. [DOI: 10.1111/apt.16437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
322 Malec M, Shega JW. Management of Gastrointestinal Symptoms (Nausea, Anorexia and Cachexia, Constipation) in Advanced Illness. Med Clin North Am 2020;104:439-54. [PMID: 32312408 DOI: 10.1016/j.mcna.2019.12.005] [Reference Citation Analysis]
323 Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA 2021;325:865. [DOI: 10.1001/jama.2020.22532] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
324 Chesnel C, Hentzen C, Haddad R, Charlanes A, Le Breton F, Turmel N, Amarenco G. Adherence to transanal irrigation in older adults: first-year assessment. Tech Coloproctol 2021;25:1055-63. [PMID: 34185193 DOI: 10.1007/s10151-021-02479-8] [Reference Citation Analysis]
325 Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:693-703. [PMID: 27492648 DOI: 10.1111/apt.13746] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 20.6] [Reference Citation Analysis]
326 Chu C, Rotondo-Trivette S, Michail S. Chronic diarrhea. Curr Probl Pediatr Adolesc Health Care 2020;50:100841. [PMID: 32863166 DOI: 10.1016/j.cppeds.2020.100841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
327 Patel N, Lacy B. Does Yoga Help Patients With Irritable Bowel Syndrome? Clin Gastroenterol Hepatol 2016;14:1732-4. [PMID: 27552854 DOI: 10.1016/j.cgh.2016.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
328 Zhao Y, Ren X, Qiao W, Dong L, He S, Yin Y. High-resolution Anorectal Manometry in the Diagnosis of Functional Defecation Disorder in Patients With Functional Constipation: A Retrospective Cohort Study. J Neurogastroenterol Motil 2019;25:250-7. [PMID: 30982241 DOI: 10.5056/jnm18032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Werth BL, Williams KA, Fisher MJ, Pont LG. Defining constipation to estimate its prevalence in the community: results from a national survey. BMC Gastroenterol 2019;19:75. [PMID: 31113366 DOI: 10.1186/s12876-019-0994-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
330 Vasant DH. Global prevalence of irritable bowel syndrome: time to consider factors beyond diagnostic criteria? The Lancet Gastroenterology & Hepatology 2020;5:879-80. [DOI: 10.1016/s2468-1253(20)30211-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Johnson CD, Williamson N, Janssen-van Solingen G, Arbuckle R, Johnson C, Simpson S, Staab D, Dominguez-Munoz E, Levy P, Connett G, Lerch MM. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology 2019;19:182-90. [PMID: 30528109 DOI: 10.1016/j.pan.2018.11.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
332 Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110209. [PMID: 33326819 DOI: 10.1016/j.pnpbp.2020.110209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
333 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 30.0] [Reference Citation Analysis]
334 Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. Am J Gastroenterol 2018;113:1540-9. [PMID: 30254230 DOI: 10.1038/s41395-018-0262-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
335 Benjak Horvat I, Gobin I, Kresović A, Hauser G. How can probiotic improve irritable bowel syndrome symptoms? WJGS 2021;13:923-40. [DOI: 10.4240/wjgs.v13.i9.923] [Reference Citation Analysis]
336 Fan F, Tang Y, Dai H, Cao Y, Sun P, Chen Y, Chen A, Lin C. Blockade of BDNF signalling attenuates chronic visceral hypersensitivity in an IBS-like rat model. Eur J Pain 2020;24:839-50. [PMID: 31976585 DOI: 10.1002/ejp.1534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
337 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol. 2017;23:6593-6627. [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
338 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1. Journal of Endocrinology 2018;239:241-52. [DOI: 10.1530/joe-18-0441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 5.7] [Reference Citation Analysis]
339 Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ Microbiol 2018;20:3201-13. [PMID: 29749705 DOI: 10.1111/1462-2920.14271] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
340 Nybacka S, Öhman L, Störsrud S, Mybeck M, Böhn L, Wilpart K, Winkvist A, Bengtsson U, Törnblom H, Simrén M. Neither self-reported atopy nor IgE-mediated allergy are linked to gastrointestinal symptoms in patients with irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13379. [PMID: 29856100 DOI: 10.1111/nmo.13379] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
341 Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. [PMID: 28274109 DOI: 10.5056/jnm16214] [Cited by in Crossref: 216] [Cited by in F6Publishing: 132] [Article Influence: 54.0] [Reference Citation Analysis]
342 Jehangir A, Parkman HP. Rome IV Diagnostic Questionnaire Complements Patient Assessment of Gastrointestinal Symptoms for Patients with Gastroparesis Symptoms. Dig Dis Sci 2018;63:2231-43. [PMID: 29808246 DOI: 10.1007/s10620-018-5125-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
343 Bai T, Xia J, Jiang Y, Cao H, Zhao Y, Zhang L, Wang H, Song J, Hou X. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey. J Gastroenterol Hepatol. 2017;32:1018-1025. [PMID: 27862281 DOI: 10.1111/jgh.13642] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
344 Fukumura K, Yokota T, Baba Y, Arjona Ferreira JC. Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers. Clin Pharmacol Drug Dev 2018;7:474-83. [PMID: 28960888 DOI: 10.1002/cpdd.387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
345 Brenner L, Zerlin L, Tan LL. Functional disruption of cortical cingulate activity attenuates visceral hypersensitivity and anxiety induced by acute experimental colitis. Sci Rep 2021;11:2103. [PMID: 33483524 DOI: 10.1038/s41598-021-81256-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
346 Wylezinski LS, Gray JD, Polk JB, Harmata AJ, Spurlock CF 3rd. Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. J Clin Med 2019;8:E493. [PMID: 30979036 DOI: 10.3390/jcm8040493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
347 Barbaro MR, Fuschi D, Cremon C, Carapelle M, Dino P, Marcellini MM, Dothel G, De Ponti F, Stanghellini V, Barbara G. Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators. Neurogastroenterol Motil 2018;30:e13388. [DOI: 10.1111/nmo.13388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
348 Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC. Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study. Pain 2018;159:987-94. [PMID: 29419653 DOI: 10.1097/j.pain.0000000000001174] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
349 Zhang Y, Feng L, Wang X, Fox M, Luo L, Du L, Chen B, Chen X, He H, Zhu S, Hu Z, Chen S, Long Y, Zhu Y, Xu L, Deng Y, Misselwitz B, Lang BM, Yilmaz B, Kim JJ, Owyang C, Dai N. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.Am J Clin Nutr. 2021;. [PMID: 33740048 DOI: 10.1093/ajcn/nqab005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
350 Ikee R, Sasaki N, Yasuda T, Fukazawa S. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet. Microorganisms 2020;8:E1862. [PMID: 33255763 DOI: 10.3390/microorganisms8121862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
351 Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simrén M, Lembo A, Young-Fadok TM, Chang L. Chronic constipation. Nat Rev Dis Primers 2017;3:17095. [PMID: 29239347 DOI: 10.1038/nrdp.2017.95] [Cited by in Crossref: 84] [Cited by in F6Publishing: 52] [Article Influence: 21.0] [Reference Citation Analysis]
352 Melchior C, Bril L, Leroi A, Gourcerol G, Ducrotté P. Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study. Neurogastroenterol Motil 2018;30:e13290. [DOI: 10.1111/nmo.13290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
353 Shah ED, Almario CV, Spiegel BMR, Chey WD. Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation. J Neurogastroenterol Motil 2018;24:299-306. [PMID: 29605985 DOI: 10.5056/jnm17112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
354 Brenner DM, Stern E, Cash BD. Opioid-Related Constipation in Patients With Non-cancer Pain Syndromes: a Review of Evidence-Based Therapies and Justification for a Change in Nomenclature. Curr Gastroenterol Rep 2017;19:12. [PMID: 28337726 DOI: 10.1007/s11894-017-0560-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
355 Clevers E, Tack J, Törnblom H, Ringström G, Luyckx K, Simrén M, Van Oudenhove L. Development of Irritable Bowel Syndrome Features Over a 5-year Period. Clin Gastroenterol Hepatol 2018;16:1244-1251.e1. [PMID: 29510214 DOI: 10.1016/j.cgh.2018.02.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
356 Southwell BR. Treatment of childhood constipation: a synthesis of systematic reviews and meta-analyses. Expert Rev Gastroenterol Hepatol 2020;14:163-74. [PMID: 32098515 DOI: 10.1080/17474124.2020.1733974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
357 Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis. 2017;11:1420-1429. [PMID: 28525543 DOI: 10.1093/ecco-jcc/jjx073] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 18.3] [Reference Citation Analysis]
358 Skardoon GR, Khera AJ, Emmanuel AV, Burgell RE. Review article: dyssynergic defaecation and biofeedback therapy in the pathophysiology and management of functional constipation. Aliment Pharmacol Ther. 2017;46:410-423. [PMID: 28660663 DOI: 10.1111/apt.14174] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
359 Lacy BE, Cangemi D, Vazquez-roque M. Management of Chronic Abdominal Distension and Bloating. Clinical Gastroenterology and Hepatology 2021;19:219-231.e1. [DOI: 10.1016/j.cgh.2020.03.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
360 Kim Y, Choi CH. Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2018;24:161-3. [PMID: 29605972 DOI: 10.5056/jnm18057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
361 Keating GM. Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome. Drugs 2017;77:1009-16. [DOI: 10.1007/s40265-017-0756-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
362 Pinto-sanchez MI, Nardelli A, Borojevic R, De Palma G, Calo NC, Mccarville J, Caminero A, Basra D, Mordhorst A, Ignatova E, Hansen S, Uhde M, Norman GL, Murray JA, Smecuol E, Armstrong D, Bai JC, Schuppan D, Collins SM, Alaedini A, Moayyedi P, Verdu EF, Bercik P. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clinical Gastroenterology and Hepatology 2020. [DOI: 10.1016/j.cgh.2020.08.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
363 Chey WD. Elimination Diets for Irritable Bowel Syndrome: Approaching the End of the Beginning. Am J Gastroenterol 2019;114:201-3. [DOI: 10.14309/ajg.0000000000000099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
364 van Megen F, Skodje GI, Stendahl M, Veierød MB, Lundin KEA, Henriksen C. High disease burden in treated celiac patients - a web-based survey. Scand J Gastroenterol 2021;56:882-8. [PMID: 34057009 DOI: 10.1080/00365521.2021.1930146] [Reference Citation Analysis]
365 Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C. Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation. Br J Pharmacol 2019;176:950-63. [PMID: 30714145 DOI: 10.1111/bph.14608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
366 Altomare A, Di Rosa C, Imperia E, Emerenziani S, Cicala M, Guarino MPL. Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 2021;13:1506. [PMID: 33946961 DOI: 10.3390/nu13051506] [Reference Citation Analysis]
367 Dimidi E, Zdanaviciene A, Christodoulides S, Taheri S, Louis P, Duncan PI, Emami N, Crabbé R, De Castro CA, McLean P, Bergonzelli GE, Whelan K, Mark Scott S. Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation. Aliment Pharmacol Ther 2019;49:251-64. [PMID: 30585341 DOI: 10.1111/apt.15073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
368 Masuy I, Van Oudenhove L, Tack J, Biesiekierski JR. Effect of intragastric FODMAP infusion on upper gastrointestinal motility, gastrointestinal, and psychological symptoms in irritable bowel syndrome vs healthy controls. Neurogastroenterol Motil 2018;30. [PMID: 28762592 DOI: 10.1111/nmo.13167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
369 Staudacher HM, Whelan K. The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66:1517-1527. [PMID: 28592442 DOI: 10.1136/gutjnl-2017-313750] [Cited by in Crossref: 134] [Cited by in F6Publishing: 103] [Article Influence: 33.5] [Reference Citation Analysis]
370 Babini D, Lemos A. Risk Factors for Urinary Incontinence in Primiparous Adolescents after Vaginal Delivery: A Cohort Study. J Pediatr Adolesc Gynecol 2020;33:500-5. [PMID: 32593748 DOI: 10.1016/j.jpag.2020.06.011] [Reference Citation Analysis]
371 Emmanuel A, Mattace-Raso F, Neri MC, Petersen KU, Rey E, Rogers J. Constipation in older people: A consensus statement. Int J Clin Pract 2017;71. [PMID: 27933718 DOI: 10.1111/ijcp.12920] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
372 Davies A, Leach C, Butler C, Gregory A, Henshaw S, Minton O, Shorthose K, Batsari KM. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features. Pain 2021;162:309-18. [PMID: 32701649 DOI: 10.1097/j.pain.0000000000002024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
373 Hod K, Ringel Y, van Tilburg MAL, Ringel-Kulka T. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities. Dig Dis Sci 2019;64:1288-95. [PMID: 30565010 DOI: 10.1007/s10620-018-5352-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
374 Katsumata R, Ishii M, Lee S, Handa Y, Murao T, Fujita M, Matsumoto H, Otsuki T, Shiotani A. Cytokine Profile and Immunoglobulin E-mediated Serological Food Hypersensitivity in Patients With Irritable Bowel Syndrome With Diarrhea. J Neurogastroenterol Motil 2018;24:415-21. [PMID: 29739174 DOI: 10.5056/jnm17114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
375 Otaka M, Kikuchi-Hayakawa H, Ogura J, Ishikawa H, Yomogida Y, Ota M, Hidese S, Ishida I, Aida M, Matsuda K, Kawai M, Yoshida S, Kunugi H. Effect of Lacticaseibacillus paracasei Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in Gut Microbiota. Microorganisms 2021;9:1026. [PMID: 34068832 DOI: 10.3390/microorganisms9051026] [Reference Citation Analysis]
376 Pinto-sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin F, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology 2017;153:448-459.e8. [DOI: 10.1053/j.gastro.2017.05.003] [Cited by in Crossref: 276] [Cited by in F6Publishing: 221] [Article Influence: 69.0] [Reference Citation Analysis]
377 Momma E, Koeda M, Tanabe T, Hoshikawa Y, Hoshino S, Kawami N, Kawagoe T, Tatsuguchi A, Kaise M, Iwakiri K. Relationship between gastroesophageal reflux disease (GERD) and constipation: laxative use is common in GERD patients. Esophagus 2021;18:152-5. [PMID: 32860581 DOI: 10.1007/s10388-020-00770-5] [Reference Citation Analysis]
378 Paredes S, Cantillo S, Candido KD, Knezevic NN. An Association of Serotonin with Pain Disorders and Its Modulation by Estrogens. Int J Mol Sci 2019;20:E5729. [PMID: 31731606 DOI: 10.3390/ijms20225729] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
379 Rocha HA, Rocha TV, Nóbrega FJ, Morais LC, Diniz MF. Randomized controlled trial of Panax ginseng in patients with irritable bowel syndrome. Revista Brasileira de Farmacognosia 2018;28:218-22. [DOI: 10.1016/j.bjp.2018.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
380 Ohkuma T, Iwase M, Fujii H, Ide H, Komorita Y, Yoshinari M, Oku Y, Higashi T, Oshiro A, Nakamura U, Kitazono T. Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry. Clin Exp Nephrol 2021. [PMID: 34173920 DOI: 10.1007/s10157-021-02105-9] [Reference Citation Analysis]
381 Sjöberg F, Barkman C, Nookaew I, Östman S, Adlerberth I, Saalman R, Wold AE. Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis. PLoS One 2017;12:e0186178. [PMID: 29049404 DOI: 10.1371/journal.pone.0186178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
382 Oh SJ, Fuller G, Patel D, Khalil C, Spalding W, Nag A, Spiegel BMR, Almario CV. Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy. Am J Gastroenterol 2020;115:895-905. [PMID: 32324606 DOI: 10.14309/ajg.0000000000000614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
383 Törnblom H, Simrén M, Barbara G, Niesler B. Funding for gastrointestinal disease research in the European Union. The Lancet Gastroenterology & Hepatology 2018;3:593-5. [DOI: 10.1016/s2468-1253(18)30203-6] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
384 Fadda HM. The Route to Palatable Fecal Microbiota Transplantation. AAPS PharmSciTech 2020;21:114. [PMID: 32296975 DOI: 10.1208/s12249-020-1637-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
385 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats. J Gastroenterol Hepatol. 2018;33:232-239. [PMID: 28440889 DOI: 10.1111/jgh.13808] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
386 Sebastián Domingo JJ. Irritable bowel syndrome. Med Clin (Barc) 2021:S0025-7753(21)00334-1. [PMID: 34238582 DOI: 10.1016/j.medcli.2021.04.029] [Reference Citation Analysis]
387 Bassotti G, Usai-Satta P, Bellini M. Linaclotide for the treatment of chronic constipation. Expert Opin Pharmacother 2018;19:1261-6. [PMID: 29985664 DOI: 10.1080/14656566.2018.1494728] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
388 Ang D, Pannemans J, Vanuytsel T, Tack J. A single-center audit of the indications and clinical impact of prolonged ambulatory small intestinal manometry. Neurogastroenterol Motil 2018;30:e13357. [DOI: 10.1111/nmo.13357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
389 Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J. Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea. Eur J Gastroenterol Hepatol 2020;32:706-12. [PMID: 32317585 DOI: 10.1097/MEG.0000000000001737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
390 Matsumoto M, Yoshida M, Miura Y, Sato N, Okawa Y, Yamada M, Otaki J, Nakagami G, Sugama J, Okada S, Ohta H, Sanada H. Feasibility of the constipation point‐of‐care ultrasound educational program in observing fecal retention in the colorectum: A descriptive study. Jpn J Nurs Sci 2021;18. [DOI: 10.1111/jjns.12385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Xu HL, Zou LL, Chen MB, Wang H, Shen WM, Zheng QH, Cui WY. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis. PLoS One 2021;16:e0255160. [PMID: 34358238 DOI: 10.1371/journal.pone.0255160] [Reference Citation Analysis]
392 Chang JY, Almazar AE, Richard Locke G 3rd, Larson JJ, Atkinson EJ, Talley NJ, Saito YA. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome. Neurogastroenterol Motil. 2018;30:e13356. [PMID: 29701271 DOI: 10.1111/nmo.13356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
393 Lembo A, Rao SSC, Heimanson Z, Pimentel M. Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea. Clin Transl Gastroenterol 2020;11:e00144. [PMID: 32352714 DOI: 10.14309/ctg.0000000000000144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
394 Tack J, Stanghellini V, Mearin F, Yiannakou Y, Layer P, Coffin B, Simren M, Mackinnon J, Wiseman G, Marciniak A; IBIS-C Study group. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol 2019;19:69. [PMID: 31064345 DOI: 10.1186/s12876-019-0985-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
395 Madsen AMA, Halkjær SI, Christensen AH, Günther S, Browne PD, Kallemose T, Hansen LH, Petersen AM. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study. Scand J Gastroenterol 2021;56:761-9. [PMID: 34000958 DOI: 10.1080/00365521.2021.1915375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Camilleri M, Sellin JH, Barrett KE. Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea. Gastroenterology. 2017;152:515-532.e2. [PMID: 27773805 DOI: 10.1053/j.gastro.2016.10.014] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 9.2] [Reference Citation Analysis]
397 Simren M, Palsson OS, Whitehead WE. Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice. Curr Gastroenterol Rep. 2017;19:15. [PMID: 28374308 DOI: 10.1007/s11894-017-0554-0] [Cited by in Crossref: 107] [Cited by in F6Publishing: 67] [Article Influence: 26.8] [Reference Citation Analysis]
398 Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology 2021;160:47-62. [PMID: 33091411 DOI: 10.1053/j.gastro.2020.06.099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
399 Mohamadi J, Ghazanfari F, Drikvand FM. Comparison of the Effect of Dialectical Behavior Therapy, Mindfulness Based Cognitive Therapy and Positive Psychotherapy on Perceived Stress and Quality of Life in Patients with Irritable Bowel Syndrome: a Pilot Randomized Controlled Trial. Psychiatr Q 2019;90:565-78. [DOI: 10.1007/s11126-019-09643-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
400 Hamrefors V, Fedorowski A, Ohlsson B. Susceptibility to diarrhea is related to hemodynamic markers of sympathetic activation in the general population. Scand J Gastroenterol 2019;54:1426-32. [PMID: 31791149 DOI: 10.1080/00365521.2019.1697742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
401 Scott SM, Simrén M, Farmer AD, Dinning PG, Carrington EV, Benninga MA, Burgell RE, Dimidi E, Fikree A, Ford AC, Fox M, Hoad CL, Knowles CH, Krogh K, Nugent K, Remes-Troche JM, Whelan K, Corsetti M. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation. Neurogastroenterol Motil 2021;33:e14050. [PMID: 33263938 DOI: 10.1111/nmo.14050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Liu Y, Gao X, Ding Y, Zhou Y, Liu X, Wang H, Wang Q, Ma B, Yao S. Effectiveness and safety of light vegetarian diet on functional constipation with gastrointestinal damp-heat pattern: An exploratory study protocol for randomized controlled trial. Medicine (Baltimore) 2019;98:e18325. [PMID: 31852124 DOI: 10.1097/MD.0000000000018325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
403 Bassotti G, Gambaccini D, Bellini M. Velusetrag for the treatment of chronic constipation. Expert Opinion on Investigational Drugs 2016;25:985-90. [DOI: 10.1080/13543784.2016.1195369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
404 Whitehead WE, Palsson OS, Simrén M. Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation. Neurogastroenterol Motil 2016;28:783-92. [PMID: 27214096 DOI: 10.1111/nmo.12852] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
405 Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020;17:473-86. [DOI: 10.1038/s41575-020-0286-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 27.0] [Reference Citation Analysis]
406 Nickerson AJ, Rajendran VM. Flupirtine enhances NHE-3-mediated Na+ absorption in rat colon via an ENS-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2021;321:G185-99. [PMID: 34132108 DOI: 10.1152/ajpgi.00158.2021] [Reference Citation Analysis]
407 Polster AV, Palsson OS, Törnblom H, Öhman L, Sperber AD, Whitehead WE, Simrén M. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study. Neurogastroenterol Motil 2019;31:e13483. [PMID: 30393924 DOI: 10.1111/nmo.13483] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
408 Videlock EJ, Mahurkar-Joshi S, Hoffman JM, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L. Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation. Am J Physiol Gastrointest Liver Physiol 2018;315:G140-57. [PMID: 29565640 DOI: 10.1152/ajpgi.00288.2017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
409 Zinsmeister AR, Herrick LM, Saito Loftus YA, Schleck CD, Talley NJ. Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study. Scandinavian Journal of Gastroenterology 2018;53:549-58. [DOI: 10.1080/00365521.2017.1395908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
410 Hill SS, Davids JS. Surgical Evaluation and Management of Constipation. Dis Colon Rectum 2019;62:661-4. [PMID: 31094958 DOI: 10.1097/DCR.0000000000001395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
411 Linninge C, Roth B, Erlanson-Albertsson C, Molin G, Toth E, Ohlsson B. Abundance of Enterobacteriaceae in the colon mucosa in diverticular disease. World J Gastrointest Pathophysiol 2018;9:18-27. [PMID: 29487763 DOI: 10.4291/wjgp.v9.i1.18] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
412 Albusoda A, Ruffle JK, Friis KA, Gysan MR, Drewes AM, Aziz Q, Farmer AD. Systematic review with meta-analysis: conditioned pain modulation in patients with the irritable bowel syndrome. Aliment Pharmacol Ther 2018;48:797-806. [DOI: 10.1111/apt.14965] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
413 Lockyer S, Stanner S. Prebiotics – an added benefit of some fibre types. Nutr Bull 2019;44:74-91. [DOI: 10.1111/nbu.12366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
414 van Thiel IAM, de Jonge WJ, Chiu IM, van den Wijngaard RM. Microbiota-neuroimmune cross talk in stress-induced visceral hypersensitivity of the bowel. Am J Physiol Gastrointest Liver Physiol 2020;318:G1034-41. [PMID: 32308040 DOI: 10.1152/ajpgi.00196.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Manning LP, Biesiekierski JR. Use of dietary interventions for functional gastrointestinal disorders. Current Opinion in Pharmacology 2018;43:132-8. [DOI: 10.1016/j.coph.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
416 Kolacz J, Porges SW. Chronic Diffuse Pain and Functional Gastrointestinal Disorders After Traumatic Stress: Pathophysiology Through a Polyvagal Perspective. Front Med (Lausanne) 2018;5:145. [PMID: 29904631 DOI: 10.3389/fmed.2018.00145] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
417 Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, Sood A. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial. J Gastroenterol Hepatol 2021;36:2107-15. [PMID: 33464683 DOI: 10.1111/jgh.15410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
418 Sinagra E, Rossi F, Raimondo D, Conoscenti G, Anderloni A, Guarnotta V, Maida M. Tenapanor for the treatment of irritable bowel syndrome with constipation. Expert Rev Clin Pharmacol 2020;13:473-9. [PMID: 32478632 DOI: 10.1080/17512433.2020.1762570] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clin Gastroenterol Hepatol 2020;18:392-398.e2. [PMID: 31154027 DOI: 10.1016/j.cgh.2019.05.037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
420 Rey E, Mearin F, Alcedo J, Ciriza C, Delgado-Aros S, Freitas T, Mascarenhas M, Mínguez M, Santos J, Serra J. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report. Adv Ther 2017;34:587-98. [PMID: 28083815 DOI: 10.1007/s12325-016-0473-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
421 Brenner DM, Dove LS, Andrae DA, Covington PS, Gutman C, Chey WD. Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea. Neurogastroenterol Motil 2018;30:e13331. [DOI: 10.1111/nmo.13331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
422 Timmerman MEW, Trzpis M, Broens PMA. The problem of defecation disorders in children is underestimated and easily goes unrecognized: a cross-sectional study. Eur J Pediatr 2019;178:33-9. [PMID: 30264351 DOI: 10.1007/s00431-018-3243-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
423 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
424 Vitellio P, Celano G, Bonfrate L, Gobbetti M, Portincasa P, De Angelis M. Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study. Nutrients 2019;11:E886. [PMID: 31010241 DOI: 10.3390/nu11040886] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
425 Schiller LR, Pardi DS, Sellin JH. Chronic Diarrhea: Diagnosis and Management. Clin Gastroenterol Hepatol. 2017;15:182-193.e3. [PMID: 27496381 DOI: 10.1016/j.cgh.2016.07.028] [Cited by in Crossref: 70] [Cited by in F6Publishing: 41] [Article Influence: 14.0] [Reference Citation Analysis]
426 Vollebregt PF, Burgell RE, Hooper RL, Knowles CH, Scott SM. Clinical Impact of Rectal Hyposensitivity: A Cross-Sectional Study of 2,876 Patients With Refractory Functional Constipation. Am J Gastroenterol 2021;116:758-68. [PMID: 33982946 DOI: 10.14309/ajg.0000000000001039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Taylor DCA, Abel JL, Martin C, Doshi JA, Essoi B, Korrer S, Reasner DS, Carson RT, Hunter AG. Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR). Journal of Medical Economics 2020;23:1072-83. [DOI: 10.1080/13696998.2020.1799816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
428 Patimah AW, Lee YY, Dariah MY. Frequency patterns of core constipation symptoms among the Asian adults: a systematic review. BMC Gastroenterol 2017;17:115. [PMID: 29096625 DOI: 10.1186/s12876-017-0672-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
429 Kavanagh RG, O'Grady J, Carey BW, O'Connor OJ, Maher MM. Review of the role of abdominal imaging in irritable bowel syndrome. World J Radiol 2018;10:143-9. [PMID: 30568748 DOI: 10.4329/wjr.v10.i11.143] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
430 Usai-Satta P, Bassotti G, Bellini M, Oppia F, Lai M, Cabras F. Irritable Bowel Syndrome and Gluten-Related Disorders. Nutrients 2020;12:E1117. [PMID: 32316404 DOI: 10.3390/nu12041117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
431 Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. Neurogastroenterol Motil 2018;30:e13189. [DOI: 10.1111/nmo.13189] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
432 Zhao Q, Chen YY, Xu DQ, Yue SJ, Fu RJ, Yang J, Xing LM, Tang YP. Action Mode of Gut Motility, Fluid and Electrolyte Transport in Chronic Constipation. Front Pharmacol 2021;12:630249. [PMID: 34385914 DOI: 10.3389/fphar.2021.630249] [Reference Citation Analysis]
433 Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut 2019;69:74-82. [DOI: 10.1136/gutjnl-2018-318160] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 23.0] [Reference Citation Analysis]
434 Swami T, Weber HC. Updates on the biology of serotonin and tryptophan hydroxylase. Curr Opin Endocrinol Diabetes Obes 2018;25:12-21. [PMID: 29194046 DOI: 10.1097/MED.0000000000000383] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
435 Talley NJ, Holtmann G, Nguyen QN, Gibson P, Bampton P, Veysey M, Wong J, Philcox S, Koloski N, Bunby L, Jones M. Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain. J Gastroenterol Hepatol 2017;32:1813-7. [PMID: 28332731 DOI: 10.1111/jgh.13791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
436 Cremon C, Barbaro MR, Ventura M, Barbara G. Pre- and probiotic overview. Curr Opin Pharmacol. 2018;43:87-92. [PMID: 30219638 DOI: 10.1016/j.coph.2018.08.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 14.3] [Reference Citation Analysis]
437 Heemskerk SCM, Rotteveel AH, Benninga MA, Baeten CIM, Masclee AAM, Melenhorst J, van Kuijk SMJ, Dirksen CD, Breukink SO. Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis. Int J Colorectal Dis 2018;33:493-501. [PMID: 29470731 DOI: 10.1007/s00384-018-2978-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
438 Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, Brunetta E, Tsantes AE, Bonovas S. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. J Clin Med 2021;10:377. [PMID: 33498197 DOI: 10.3390/jcm10030377] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
439 Lee YJ. Is There a Role for Radiopaque Markers in Identifying Defecation Disorders? J Neurogastroenterol Motil 2021;27:312-3. [PMID: 34210897 DOI: 10.5056/jnm21115] [Reference Citation Analysis]
440 Galli G, Carabotti M, Pilozzi E, Lahner E, Annibale B, Conti L. Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients. Nutrients 2021;13:600. [PMID: 33673062 DOI: 10.3390/nu13020600] [Reference Citation Analysis]
441 Pauwels A, Boecxstaens V, Andrews CN, Attwood SE, Berrisford R, Bisschops R, Boeckxstaens GE, Bor S, Bredenoord AJ, Cicala M, Corsetti M, Fornari F, Gyawali CP, Hatlebakk J, Johnson SB, Lerut T, Lundell L, Mattioli S, Miwa H, Nafteux P, Omari T, Pandolfino J, Penagini R, Rice TW, Roelandt P, Rommel N, Savarino V, Sifrim D, Suzuki H, Tutuian R, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Tack J. How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery). Gut. 2019;68:1928-1941. [PMID: 31375601 DOI: 10.1136/gutjnl-2019-318260] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 15.0] [Reference Citation Analysis]
442 Zhou W, Li X, Huang Y, Xu X, Liu Y, Wang J, Nie G, Zhou D. Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults: A systematic review and network meta-analysis. Medicine (Baltimore) 2021;100:e26046. [PMID: 34011118 DOI: 10.1097/MD.0000000000026046] [Reference Citation Analysis]
443 Huang Z, Li S, Foreman RD, Yin J, Dai N, Chen JDZ. Sacral nerve stimulation with appropriate parameters improves constipation in rats by enhancing colon motility mediated via the autonomic-cholinergic mechanisms. Am J Physiol Gastrointest Liver Physiol 2019;317:G609-17. [PMID: 31411502 DOI: 10.1152/ajpgi.00150.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
444 Koutouratsas T, Kalli T, Karamanolis G, Gazouli M. Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis. World J Gastroenterol 2019;25:539-51. [PMID: 30774270 DOI: 10.3748/wjg.v25.i5.539] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
445 Zejnelagic J, Ohlsson B. Chronic stress and poor sleeping habits are associated with self-reported IBS and poor psychological well-being in the general population. BMC Res Notes 2021;14:280. [PMID: 34294119 DOI: 10.1186/s13104-021-05688-4] [Reference Citation Analysis]
446 Wei L, Singh R, Ha SE, Martin AM, Jones LA, Jin B, Jorgensen BG, Zogg H, Chervo T, Gottfried-Blackmore A, Nguyen L, Habtezion A, Spencer NJ, Keating DJ, Sanders KM, Ro S. Serotonin Deficiency Is Associated With Delayed Gastric Emptying. Gastroenterology 2021;160:2451-2466.e19. [PMID: 33662386 DOI: 10.1053/j.gastro.2021.02.060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
447 Meinds RJ, Timmerman MEW, van Meegdenburg MM, Trzpis M, Broens PMA. Reproducibility, feasibility and validity of the Groningen Defecation and Fecal Continence questionnaires. Scand J Gastroenterol 2018;53:790-6. [PMID: 29703095 DOI: 10.1080/00365521.2018.1465993] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
448 Prusator DK, Chang L. Sex-Related Differences in GI Disorders. Handb Exp Pharmacol 2017;239:177-92. [PMID: 28233176 DOI: 10.1007/164_2016_121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
449 Chelimsky G, Chelimsky T. The gastrointestinal symptoms present in patients with postural tachycardia syndrome: A review of the literature and overview of treatment. Auton Neurosci 2018;215:70-7. [PMID: 30245098 DOI: 10.1016/j.autneu.2018.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
450 Polster A, Friberg P, Gunterberg V, Öhman L, Le Nevé B, Törnblom H, Cvijovic M, Simren M. Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms. Neurogastroenterol Motil 2018;30:e13320. [DOI: 10.1111/nmo.13320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
451 Rabitti S, Giovanardi CM, Colussi D. Acupuncture and Related Therapies for the Treatment of Gastrointestinal Diseases. J Clin Gastroenterol 2021;55:207-17. [PMID: 33116064 DOI: 10.1097/MCG.0000000000001455] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
452 Corsetti M, Whorwell P. The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol 2017;10:727-36. [PMID: 28932273 DOI: 10.1177/1756283X17718677] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
453 Sebastián Domingo JJ. The new Rome criteria (IV) of functional digestive disorders in clinical practice. Med Clin (Barc) 2017;148:464-8. [PMID: 28153434 DOI: 10.1016/j.medcli.2016.12.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
454 Zhang X, Li L, Li SL, Li SX, Wang XY, Tang ST. Primary laparoscopic endorectal pull-through procedure with or without a postoperative rectal tube for hirschsprung disease: a multicenter perspective study. J Pediatr Surg 2020;55:381-6. [PMID: 31296328 DOI: 10.1016/j.jpedsurg.2019.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
455 Soncini M, Stasi C, Usai Satta P, Milazzo G, Bianco M, Leandro G, Montalbano LM, Muscatiello N, Monica F, Galeazzi F, Bellini M; AIGO. IBS clinical management in Italy: The AIGO survey. Dig Liver Dis 2019;51:782-9. [PMID: 30448159 DOI: 10.1016/j.dld.2018.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
456 Abdulahad S, Huls H, Balikji S, van de Loo AJAE, Roth T, Verster JC. Irritable Bowel Syndrome, Immune Fitness, and Insomnia: Results from an Online Survey Among People Reporting Sleep Complaints. Sleep Vigilance 2019;3:121-9. [DOI: 10.1007/s41782-019-00066-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
457 Sarrió RG, Calsina-Berna A, García AG, Esparza-Miñana JM, Ferrer EF, Porta-Sales J; Working Group ActEIO Project. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliat Care 2021;20:1. [PMID: 33388041 DOI: 10.1186/s12904-020-00693-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Pannemans J, Masuy I, Tack J. Functional Constipation: Individualising Assessment and Treatment. Drugs 2020;80:947-63. [PMID: 32451924 DOI: 10.1007/s40265-020-01305-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
459 Goodoory VC, Houghton LA, Yiannakou Y, Black CJ, Ford AC. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00501-2. [PMID: 33957271 DOI: 10.1016/j.cgh.2021.04.043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 Prospero L, Riezzo G, Linsalata M, Orlando A, D'Attoma B, Di Masi M, Martulli M, Russo F. Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity. BMC Gastroenterol 2021;21:235. [PMID: 34022802 DOI: 10.1186/s12876-021-01820-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Kortlever TL, Ten Bokkel Huinink S, Offereins M, Hebblethwaite C, O'Brien L, Leeper J, Mulder CJJ, Barrett JS, Gearry RB. Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study. Nutr Clin Pract 2019;34:623-30. [PMID: 30644587 DOI: 10.1002/ncp.10233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
462 Shah SL, Janisch NH, Crowell M, Lacy BE. Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clinical Gastroenterology and Hepatology 2021;19:80-6. [DOI: 10.1016/j.cgh.2020.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
463 Talley NJ. What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model. Am J Gastroenterol 2020;115:41-8. [PMID: 31895721 DOI: 10.14309/ajg.0000000000000485] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 22.0] [Reference Citation Analysis]
464 Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 2019;109:1098-111. [DOI: 10.1093/ajcn/nqy376] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
465 Dossett ML, Cohen EM, Cohen J. Integrative Medicine for Gastrointestinal Disease. Prim Care 2017;44:265-80. [PMID: 28501229 DOI: 10.1016/j.pop.2017.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
466 Morishita D, Tomita T, Mori S, Kimura T, Oshima T, Fukui H, Miwa H. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol 2021;116:152-61. [PMID: 32969946 DOI: 10.14309/ajg.0000000000000942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
467 Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR. Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Aliment Pharmacol Ther 2017;45:824-32. [PMID: 28105700 DOI: 10.1111/apt.13949] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
468 Chatoo M, Li Y, Ma Z, Coote J, Du J, Chen X. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome. Front Endocrinol (Lausanne) 2018;9:21. [PMID: 29483895 DOI: 10.3389/fendo.2018.00021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
469 Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018;113:1-18. [PMID: 29950604 DOI: 10.1038/s41395-018-0084-x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 99] [Article Influence: 70.0] [Reference Citation Analysis]
470 Dimidi E, Mark Scott S, Whelan K. Probiotics and constipation: mechanisms of action, evidence for effectiveness and utilisation by patients and healthcare professionals. Proc Nutr Soc 2020;79:147-57. [PMID: 31262376 DOI: 10.1017/S0029665119000934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
471 Long Y, Huang Z, Deng Y, Chu H, Zheng X, Yang J, Zhu Y, Fried M, Fox M, Dai N. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil. 2017;29. [PMID: 27412422 DOI: 10.1111/nmo.12897] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
472 Walters JRF, Arasaradnam R, Andreyev HJN; UK Bile Acid Related Diarrhoea Network . Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice. Frontline Gastroenterol 2020;11:358-63. [PMID: 32879719 DOI: 10.1136/flgastro-2019-101301] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
473 Grover M, Kolla BP, Pamarthy R, Mansukhani MP, Breen-Lyles M, He JP, Merikangas KR. Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults. PLoS One 2021;16:e0245323. [PMID: 33444383 DOI: 10.1371/journal.pone.0245323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
474 Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update. Front Psychiatry. 2020;11:664. [PMID: 32754068 DOI: 10.3389/fpsyt.2020.00664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
475 Nag A, Martin SA, Mladsi D, Olayinka-Amao O, Purser M, Vekaria RM. The Humanistic and Economic Burden of Chronic Idiopathic Constipation in the USA: A Systematic Literature Review. Clin Exp Gastroenterol 2020;13:255-65. [PMID: 32765039 DOI: 10.2147/CEG.S239205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
476 Attard A, Iles A, Attard S, Atkinson N, Patel A. Clozapine: why wait to start a laxative? BJPsych advances 2019;25:377-86. [DOI: 10.1192/bja.2019.42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
477 Peiris M, Weerts ZZRM, Aktar R, Masclee AAM, Blackshaw A, Keszthelyi D. A putative anti-inflammatory role for TRPM8 in irritable bowel syndrome-An exploratory study. Neurogastroenterol Motil 2021;:e14170. [PMID: 34145938 DOI: 10.1111/nmo.14170] [Reference Citation Analysis]
478 Talley NJ, Powell N, Walker MM, Jones MP, Ronkainen J, Forsberg A, Kjellström L, Hellström PM, Aro P, Wallner B, Agréus L, Andreasson A. Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies. Aliment Pharmacol Ther 2021;54:32-42. [PMID: 33983640 DOI: 10.1111/apt.16372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
479 Nilholm C, Larsson E, Roth B, Gustafsson R, Ohlsson B. Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients. Nutrients 2019;11:E1279. [PMID: 31195706 DOI: 10.3390/nu11061279] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
480 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
481 Kuronen M, Hantunen S, Alanne L, Kokki H, Saukko C, Sjövall S, Vesterinen K, Kokki M. Pregnancy, puerperium and perinatal constipation - an observational hybrid survey on pregnant and postpartum women and their age-matched non-pregnant controls. BJOG 2021;128:1057-64. [PMID: 33030260 DOI: 10.1111/1471-0528.16559] [Reference Citation Analysis]
482 Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology 2020;5:117-31. [DOI: 10.1016/s2468-1253(19)30324-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 2] [Article Influence: 33.0] [Reference Citation Analysis]
483 Brown TJ, Keshvani N, Gupta A, Yang H, Agrawal D, Le TC, Gerber DE, Alvarez CA. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study. Support Care Cancer 2020;28:5315-21. [DOI: 10.1007/s00520-020-05364-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
484 Hammer J. Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test. American Journal of Gastroenterology 2018;113:584-92. [DOI: 10.1038/ajg.2018.16] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
485 Ohno H, Murakami H, Tanisawa K, Konishi K, Miyachi M. Validity of an observational assessment tool for multifaceted evaluation of faecal condition. Sci Rep 2019;9:3760. [PMID: 30842504 DOI: 10.1038/s41598-019-40178-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
486 Otani K, Watanabe T, Takahashi K, Nadatani Y, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Taira K, Nagami Y, Kimura T, Fukumoto S, Kawada N, Fujiwara Y. Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check-up in Japan. J Gastroenterol Hepatol 2021;36:2157-64. [PMID: 33555082 DOI: 10.1111/jgh.15436] [Reference Citation Analysis]
487 Trott N, Aziz I, Rej A, Surendran Sanders D. How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study. Nutrients 2019;11:E1313. [PMID: 31212668 DOI: 10.3390/nu11061313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
488 Jones MP, Shah A, Ben-Jacob R, Talley NJ, Hansen T, Walker MM, Gray M, Koloski NA, Holtmann G. Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases. Neurogastroenterol Motil 2021;33:e14091. [PMID: 33512740 DOI: 10.1111/nmo.14091] [Reference Citation Analysis]
489 Altomare A, Del Chierico F, Rocchi G, Emerenziani S, Nuglio C, Putignani L, Angeletti S, Lo Presti A, Ciccozzi M, Russo A, Cocca S, Ribolsi M, Muscaritoli M, Cicala M, Guarino MPL. Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study. Nutrients 2021;13:1479. [PMID: 33925672 DOI: 10.3390/nu13051479] [Reference Citation Analysis]
490 Mei L, Zhou J, Su Y, Mao K, Wu J, Zhu C, He L, Cui Y. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol 2021;21:105. [PMID: 33663411 DOI: 10.1186/s12876-021-01693-w] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
491 Carpinelli L, Bucci C, Santonicola A, Zingone F, Ciacci C, Iovino P. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain. Neurogastroenterol Motil. 2019;31:e13531. [PMID: 30628137 DOI: 10.1111/nmo.13531] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
492 Serrano-falcón B, Rey E. The safety of available treatments for chronic constipation. Expert Opinion on Drug Safety 2017;16:1243-53. [DOI: 10.1080/14740338.2017.1361402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
493 Singh P, Lee HN, Rangan V, Ballou S, Lembo J, Katon J, McMahon C, Friedlander D, Iturrino J, Nee J, Lembo A. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol 2020;18:399-405.e1. [PMID: 31442602 DOI: 10.1016/j.cgh.2019.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
494 Chen C, Chen Y, Liou J, Wu M; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. From germ theory to germ therapy. Kaohsiung J Med Sci 2019;35:73-82. [DOI: 10.1002/kjm2.12011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
495 Neubauer K, Bednarz-Misa I, Walecka-Zacharska E, Wierzbicki J, Agrawal A, Gamian A, Krzystek-Korpacka M. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia. Int J Mol Sci. 2019;20. [PMID: 30621173 DOI: 10.3390/ijms20010166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
496 Oświęcimska J, Szymlak A, Roczniak W, Girczys-Połedniok K, Kwiecień J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci 2017;62:17-30. [PMID: 28135659 DOI: 10.1016/j.advms.2016.11.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 13.8] [Reference Citation Analysis]
497 Goyal O, Bansal M, Sood A. Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome. Indian J Gastroenterol 2019;38:211-9. [DOI: 10.1007/s12664-019-00953-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
498 Weltens N, Iven J, Van Oudenhove L, Kano M. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci 2018;1428:129-50. [PMID: 30255954 DOI: 10.1111/nyas.13969] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
499 Sarica AS, Bor S, Orman MN, Barajas-Martinez H, Juang JJ, Antzelevitch C, Hasdemir C. Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern. Am J Cardiol 2021;151:51-6. [PMID: 34034907 DOI: 10.1016/j.amjcard.2021.04.010] [Reference Citation Analysis]
500 Barbalho SM, Goulart RA, Araújo AC, Guiguer ÉL, Bechara MD. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol 2019;13:345-59. [PMID: 30791775 DOI: 10.1080/17474124.2019.1570137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
501 Chabane H, Doyen V, Bienvenu F, Adel-patient K, Vitte J, Mariotte D, Bienvenu J. Les dosages d’IgG anti-aliments : méthodes et pertinence clinique des résultats. Position du groupe de travail de biologie de la Société française d’allergologie. Revue Française d'Allergologie 2018;58:334-57. [DOI: 10.1016/j.reval.2018.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
502 Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust 2018;209:86-91. [PMID: 29996755 DOI: 10.5694/mja18.00241] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
503 Oh SJ, Tashjian VC, Mirocha J, Nagar M, Mathur R, Lin E, Chua KS, Rezaie A, Pimentel M, Pichetshote N. Declining Rates of Referral for Irritable Bowel Syndrome Without Constipation at a Tertiary Care Center. Dig Dis Sci 2019;64:182-8. [PMID: 30324554 DOI: 10.1007/s10620-018-5302-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
504 Okumura T, Ishioh M, Nozu T. Central regulatory mechanisms of visceral sensation in response to colonic distension with special reference to brain orexin. Neuropeptides 2021;86:102129. [PMID: 33636498 DOI: 10.1016/j.npep.2021.102129] [Reference Citation Analysis]
505 Schwille-Kiuntke J, Rüdlin SL, Junne F, Enck P, Brenk-Franz K, Zipfel S, Rieger MA. Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey. BMC Fam Pract 2021;22:154. [PMID: 34275465 DOI: 10.1186/s12875-021-01499-5] [Reference Citation Analysis]
506 Rawla P, Sunkara T, Raj JP. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Life Sciences 2018;212:176-81. [DOI: 10.1016/j.lfs.2018.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
507 Liu YW, Wang YP, Yen HF, Liu PY, Tzeng WJ, Tsai CF, Lin HC, Lee FY, Jeng OJ, Lu CL, Tsai YC. Lactobacillus plantarum PS128 Ameliorated Visceral Hypersensitivity in Rats Through the Gut-Brain Axis. Probiotics Antimicrob Proteins 2020;12:980-93. [PMID: 31691208 DOI: 10.1007/s12602-019-09595-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
508 Abel JL, Carson RT, Andrae DA. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea. Qual Life Res 2019;28:369-77. [PMID: 30267294 DOI: 10.1007/s11136-018-2008-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
509 Sperber AD. Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective. Gastroenterol Clin North Am 2021;50:489-503. [PMID: 34304784 DOI: 10.1016/j.gtc.2021.04.001] [Reference Citation Analysis]
510 Black CJ, Ford AC. Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Aliment Pharmacol Ther 2017;46:697-697. [DOI: 10.1111/apt.14238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
511 Schiller LR. Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine: . American Journal of Gastroenterology 2018;113:660-9. [DOI: 10.1038/s41395-018-0032-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
512 Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients 2019;11:E1613. [PMID: 31315227 DOI: 10.3390/nu11071613] [Cited by in Crossref: 172] [Cited by in F6Publishing: 122] [Article Influence: 86.0] [Reference Citation Analysis]
513 Fukudo S, Miwa H, Nakajima A, Haruma K, Kosako M, Nakagawa A, Akiho H, Yamaguchi Y, Johnston JM, Currie M, Kinoshita Y. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan. Neurogastroenterol Motil 2018;30:e13444. [DOI: 10.1111/nmo.13444] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
514 Emmanuel A, Goosey RW, Wiseman G, Baker S, Törnblom H. Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D. BMC Gastroenterol 2020;20:127. [PMID: 32336287 DOI: 10.1186/s12876-020-01252-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
515 Stenlund H, Nilholm C, Chorell E, Roth B, D'Amato M, Ohlsson B. Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet. Metabolites 2021;11:440. [PMID: 34357334 DOI: 10.3390/metabo11070440] [Reference Citation Analysis]
516 Barish CF, Griffin P. Safety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label study. Current Medical Research and Opinion 2018;34:751-5. [DOI: 10.1080/03007995.2018.1430024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
517 Aboubakr A, Cohen MS. Functional Bowel Disease. Clin Geriatr Med 2021;37:119-29. [PMID: 33213766 DOI: 10.1016/j.cger.2020.08.009] [Reference Citation Analysis]
518 Stanghellini V. Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV. Dig Dis. 2017;35 Suppl 1:14-17. [PMID: 29421792 DOI: 10.1159/000485408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
519 Ji H, Kang N, Chen T, Lv L, Ma X, Wang F, Tang X. Shen-ling-bai-zhu-san, a spleen-tonifying Chinese herbal formula, alleviates lactose-induced chronic diarrhea in rats. Journal of Ethnopharmacology 2019;231:355-62. [DOI: 10.1016/j.jep.2018.07.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
520 Bellini M, Tonarelli S, Mumolo MG, Bronzini F, Pancetti A, Bertani L, Costa F, Ricchiuti A, de Bortoli N, Marchi S, Rossi A. Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome? Nutrients 2020;12:E3368. [PMID: 33139629 DOI: 10.3390/nu12113368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
521 Caldwell PH. Tips for managing treatment-resistant enuresis. J Paediatr Child Health 2018;54:1060-4. [PMID: 30294999 DOI: 10.1111/jpc.14158] [Reference Citation Analysis]
522 Bassotti G, Usai Satta P, Bellini M. Plecanatide for the treatment of chronic idiopathic constipation in adult patients. Expert Rev Clin Pharmacol 2019;12:1019-26. [PMID: 31575291 DOI: 10.1080/17512433.2019.1670057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
523 Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H. Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults. Clin Gastroenterol Hepatol 2019;17:878-86. [PMID: 29857155 DOI: 10.1016/j.cgh.2018.05.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
524 Grubišić V, McClain JL, Fried DE, Grants I, Rajasekhar P, Csizmadia E, Ajijola OA, Watson RE, Poole DP, Robson SC, Christofi FL, Gulbransen BD. Enteric Glia Modulate Macrophage Phenotype and Visceral Sensitivity following Inflammation. Cell Rep 2020;32:108100. [PMID: 32905782 DOI: 10.1016/j.celrep.2020.108100] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
525 Bassotti G, Usai Satta P, Bellini M. Prucalopride for the treatment of constipation: a view from 2015 and beyond. Expert Rev Gastroenterol Hepatol 2019;13:257-62. [PMID: 30791758 DOI: 10.1080/17474124.2019.1568238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
526 Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol 2018;3:537-47. [PMID: 29805116 DOI: 10.1016/S2468-1253(18)30123-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 18.3] [Reference Citation Analysis]
527 Vollebregt PF, Hooper RL, Farmer AD, Miller J, Knowles CH, Scott SM. Association between opioid usage and rectal dysfunction in constipation: A cross-sectional study of 2754 patients. Neurogastroenterol Motil 2020;32:e13839. [PMID: 32167628 DOI: 10.1111/nmo.13839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
528 Thompson J. Understanding the role of diet in adult constipation. Nurs Stand 2020;35:39-44. [PMID: 32755079 DOI: 10.7748/ns.2020.e11553] [Reference Citation Analysis]
529 Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota. Eur J Neurol 2017;24:1375-83. [PMID: 28891262 DOI: 10.1111/ene.13398] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
530 Harvey PR, Theron B, Smith SCL, Rastall P, Steves CJ, Harris J, Spector TD, Trudgill NJ. The association between low birth weight, childhood recollections of parental response to illness, and irritable bowel syndrome: a twin study. Neurogastroenterol Motil 2020;32:e13939. [PMID: 32715594 DOI: 10.1111/nmo.13939] [Reference Citation Analysis]
531 Zhang Y, Liu R, Wang J, Yan S, Guo Z. To assess the effective and safety of compound glutamine entersoluble capsules in irritable bowel syndrome: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25098. [PMID: 33725903 DOI: 10.1097/MD.0000000000025098] [Reference Citation Analysis]
532 Duncanson K, Burrows T, Keely S, Potter M, Das G, Walker M, Talley NJ. The Alignment of Dietary Intake and Symptom-Reporting Capture Periods in Studies Assessing Associations between Food and Functional Gastrointestinal Disorder Symptoms: A Systematic Review. Nutrients 2019;11:E2590. [PMID: 31661839 DOI: 10.3390/nu11112590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 Luo Y, Cui Z, Zou P, Wang K, Lin Z, He J, Wang J. Mental Health Problems and Associated Factors in Chinese High School Students in Henan Province: A Cross-Sectional Study. Int J Environ Res Public Health 2020;17:E5944. [PMID: 32824313 DOI: 10.3390/ijerph17165944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:17-44. [DOI: 10.14309/ajg.0000000000001036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 47.0] [Reference Citation Analysis]
535 Tang J, Li H, Tang W. Efficacy of Non-pharmacologic Auxiliary Treatments in Improving Defecation Function in Children With Chronic Idiopathic Constipation: A Systematic Review and Network Meta-analysis. Front Pediatr 2021;9:667225. [PMID: 33987155 DOI: 10.3389/fped.2021.667225] [Reference Citation Analysis]
536 Plasse TF, Barton G, Davidson E, Abramson D, Kalfus I, Fathi R, Raday G, Harris MS. Bimodal Release Ondansetron Improves Stool Consistency and Symptomatology in Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Trial. Am J Gastroenterol 2020;115:1466-73. [DOI: 10.14309/ajg.0000000000000727] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
537 Sundin J, Öhman L, Simrén M. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases. Psychosom Med 2017;79:857-67. [PMID: 28422780 DOI: 10.1097/PSY.0000000000000470] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
538 Dbar S, Akhmadullina O, Sabelnikova E, Belostotskiy N, Parfenov A, Bykova S, Bakharev S, Baulo E, Babanova A, Indeykina L, Kuzmina T, Kosacheva T, Spasenov A, Makarova A. Patients with functional bowel disorder have disaccharidase deficiency: A single-center study from Russia. World J Clin Cases 2021;9:4178-87. [PMID: 34141780 DOI: 10.12998/wjcc.v9.i17.4178] [Reference Citation Analysis]
539 Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 2019;286:490-502. [DOI: 10.1111/joim.12966] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
540 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 25.5] [Reference Citation Analysis]
541 Gómez-Escudero O, Remes-Troche JM. Approach to the adult patient with chronic diarrhea: A literature review. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00087-6. [PMID: 34389290 DOI: 10.1016/j.rgmxen.2021.08.007] [Reference Citation Analysis]
542 Staller K, Olén O, Söderling J, Roelstraete B, Törnblom H, Khalili H, Joshi AD, Nguyen LH, Song M, Kuo B, Chan AT, Ludvigsson JF. Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study. Am J Gastroenterol 2020;115:746-55. [PMID: 32108661 DOI: 10.14309/ajg.0000000000000573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
543 Asghar Z, Thoufeeq M, Kurien M, Ball AJ, Rej A, David Tai FW, Afify S, Aziz I. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31221-0. [PMID: 32882424 DOI: 10.1016/j.cgh.2020.08.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
544 Dimidi E, Cox C, Grant R, Scott SM, Whelan K. Perceptions of Constipation Among the General Public and People With Constipation Differ Strikingly From Those of General and Specialist Doctors and the Rome IV Criteria. Am J Gastroenterol 2019;114:1116-29. [DOI: 10.14309/ajg.0000000000000267] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
545 Krieger-Grübel C, Hutter S, Hiestand M, Brenner I, Güsewell S, Borovicka J. Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study. Clin Nutr ESPEN 2020;40:83-9. [PMID: 33183577 DOI: 10.1016/j.clnesp.2020.09.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
546 Liu JJ, Brenner DM. Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation. Gastroenterol Clin North Am 2021;50:639-53. [PMID: 34304792 DOI: 10.1016/j.gtc.2021.04.004] [Reference Citation Analysis]
547 Corsetti M, Whorwell P. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline. Expert Rev Gastroenterol Hepatol 2017;11:285-92. [PMID: 28276811 DOI: 10.1080/17474124.2017.1298442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
548 Barberio B, Houghton LA, Yiannakou Y, Savarino EV, Black CJ, Ford AC. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:362-71. [DOI: 10.14309/ajg.0000000000000946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
549 Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep 2020;10:11988. [PMID: 32686762 DOI: 10.1038/s41598-020-68961-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
550 Barberio B, Judge C, Savarino EV, Ford AC. Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:638-48. [PMID: 34090581 DOI: 10.1016/S2468-1253(21)00111-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
551 Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.Aliment Pharmacol Ther. 2019;50:240-248. [PMID: 31136009 DOI: 10.1111/apt.15330] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 33.0] [Reference Citation Analysis]
552 Waehrens R, Li X, Sundquist J, Sundquist K, Zöller B. Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort. Scandinavian Journal of Gastroenterology 2018;53:559-66. [DOI: 10.1080/00365521.2017.1398345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
553 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome. Eur J Pharmacol 2020;887:173565. [PMID: 32946869 DOI: 10.1016/j.ejphar.2020.173565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
554 Aziz I, Whitehead WE, Palsson OS, Törnblom H, Simrén M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol 2020;14:39-46. [PMID: 31893959 DOI: 10.1080/17474124.2020.1708718] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
555 Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4:632-642. [PMID: 31122802 DOI: 10.1016/s2468-1253(19)30089-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 24.0] [Reference Citation Analysis]
556 Krouwel M, Greenfield S, Farley A, Ismail T, Jolly K. Factors which affect the efficacy of hypnotherapy for IBS: Protocol for a systematic review and meta-regression. European Journal of Integrative Medicine 2018;21:58-62. [DOI: 10.1016/j.eujim.2018.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
557 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
558 Lo Presti A, Del Chierico F, Altomare A, Zorzi F, Cella E, Putignani L, Guarino MPL, Monteleone G, Cicala M, Angeletti S, Ciccozzi M. Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS. Future Microbiol 2019;14:1497-509. [PMID: 31850811 DOI: 10.2217/fmb-2019-0175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
559 Wiley JW, Chang L. Functional Bowel Disorders. Gastroenterology 2018;155:1-4. [PMID: 29454798 DOI: 10.1053/j.gastro.2018.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
560 Schäfer SK, Weidner KJ, Hoppner J, Becker N, Friedrich D, Stokes CS, Lammert F, Köllner V. Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure. BMC Gastroenterol 2017;17:139. [PMID: 29202711 DOI: 10.1186/s12876-017-0684-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
561 Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6. [PMID: 29072609 DOI: 10.3390/jcm6110099] [Cited by in Crossref: 121] [Cited by in F6Publishing: 76] [Article Influence: 30.3] [Reference Citation Analysis]
562 Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients 2021;13:575. [PMID: 33572262 DOI: 10.3390/nu13020575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]